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Several tetrahydroisoquinoline (TIQ) diamine derivatives were prepared for use as ligands in 
asymmetric transfer hydrogenation  (ATH) of acetophenone of which 17 intermediates and the 
eight target ligands were novel compounds.  The initial design followed that of Noyori, who 
presented the efficiency of his monotosylated diamine in ATH.  A series of eight novel 
secondary amine derivatives (78a-g and 88) were prepared with substituents that influenced the 
electronics and the sterics of and around the nitrogen donor.  Ligand 71 was shown to have no 
activity for the ATH of acetophenone.  It was apparent from experimental observations that a 
balance between the electronic and steric characteristics of the substituent was necessary to 
facilitate activity.  It was found that ligand 78d possessing a benzyl group, had the greatest 
activity (81 % conv.).  The greatest selectivity was obtained with ligand 78f (77 % ee) having a 
chiral phenylmethyl substituent.  It was discovered in the case of the active diamine ligands that 
an optimised 1500 equivalents of water was required in order to demonstrate any 
enantioselectivity.  The exact role of the water has never been ascertained, although there are 
many publications in which the effect of water has been examined.  The most active metal 
precursor was also investigated and [RhCl2(Cp*)]2 was found to be the best for these TIQ 
diamine ligands in the specified model reactions.  This work has recently been accepted for 
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Chapter 1  
1.1 Origin & Importance of Chirality  
Chirality is an expression of asymmetry, where an entity of any kind possesses a certain 
geometry which when casting a reflection of itself in a mirror, neither perspective can be 
superimposed on the other.  There are many examples to demonstrate this concept; however by 
far the most extensively used is that of the left and right hand.  When held up against one 
another (see Figure 1), the left hand can be said to be a reflection of the right hand and visa 
versa the right a reflection of the left.  However, despite their similarities it is clear that it is 
impossible to superimpose one upon the other.1-2 
 
Figure 1: Representation of chirality  
The term “chirality” was coined by the French chemist and microbiologist Louis Pasteur in 1848 
whilst studying sodium ammonium tartrate crystals.  By careful observation of the crystals, 
Pasteur was able to differentiate between the two forms.  Pasteur discovered that the two 
crystalline forms rotated plane  polarised light in opposite directions to one another but to the 
same degree.  The term “enantiomer” was used to describe these molecules that possess no plane 
of symmetry and are non-superimposable mirror images of one another.1-4   
Enantiomers, as is expected display similar spectroscopic properties, observed in Nuclear 
Magnetic Resonance (NMR) and Infrared (IR) spectroscopy; they also share similar macro 
structural and physiochemical behaviour such as melting point and solubility.  However 
enantiomers differ greatly in the direction they rotate plane-polarised light and in the way they 
interact with other chiral species.1, 4-6  
A variety of molecular components within biological organisms, are composed of or possess 
chiral molecules. These molecules are present almost entirely as one particular enantiomer; 
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examples of such are proteins, DNA, RNA and enzymes.  Chirality plays an important role in 
senses such as smell, taste and in the way a drug or hormone will bind to an inherently chiral 
enzyme or protein.  A biological response between enantiomers can differ, particularly with 
drugs and fragrances, examples are thalidomide 1 and carvone 2.  The (S)-(-) enantiomer of 
thalidomide 1a in addition to relieving nausea leads to birth defects to the foetuses of pregnant 
women users, whilst the other (R)-()+ enantiomer 1b only has a sedative effect.  Carvone 
produced by the caraway plant, has an anise type odour indicative of the (S)-(-) enantiomer 2a 















1a 1b 2a 2b  
1.2 Routes to Obtain Optically Pure Compounds  
There are three basic strategies to obtain optically pure compounds.  They are namely: the 
“chiral pool”, resolution of racemates and asymmetric synthesis.  The first two will be discussed 
briefly.  
1.3 The “Chiral Pool” Strategy 
This strategy utilises the abundant and diverse list of enantiomerically pure compounds that 
nature produces routinely, for the required application.  Typical members are amino acids, 
sugars and terpenes among others, these all fall within the “chiral pool”.  An example of a 
synthetic application of this strategy would be the preparation of aspartame 3, an artificial 
sweetener whose structure is a relatively simple dipeptide.  Employing a retro-synthetic 
approach, it can be seen that two natural amino acids; (S)-phenylalanine methyl ester 4 and (S)-
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In this instance, the chiral pool appears to be an attractive solution to obtain enantiomerically 
pure compounds.  However this is not always the case, although nature has a large supply of 
these chiral derivatives, one that suits the needs or at least mimics the desired structural features 
closely enough is not always available.  Another drawback is that these chiral compounds are 
often in small amounts within a plant or animal, sometimes requiring the organism to be 
destroyed to isolate enough material.  Despite these short comings the chiral pool still has 

















1.4 Resolution of Racemates  
Resolution in essence is the separation of an equimolar  mixture of two enantiomers (racemate), 
a difficult task given that they possess virtually identical properties.  There are several means of 
resolving racemates; (i) enzymatic methods which are naturally selective,  (ii) conversion of the 
enantiomers into diastereomers with the use of a chiral resolving agent, making them amenable 
to chromatography or recrystallisation, and finally there is (iii) chiral chromatography.1, 9  Fodor 
et al. in 1949 showed that they were able to demonstrate resolution by method (i) via selectively 
hydrolysing one enantiomer (L) from a racemic mixture of N-acetylated amino acids with the use 
of an enzyme extracted from a hog kidney.10-12 The beta blocker (S)-(-)-propanolol 8, which 
possesses one chiral centre can be purified from a racemic 7 mixture by selective precipitation of 
the (S)-isomer as a salt formed with (-)-dibenzoyl-L-tartaric acid, in this respect the (-)-dibenzoyl-
L-tartaric acid acts as the chiral resolving agent, even though a covalent bond is not formed.13  
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Chiral resolution is indeed an attractive means to obtain optically pure compounds.  However 
the major drawback in this approach is the poor yields, theoretically only 50 % can be obtained 
from a racemic mixture.  Attempts have been made to solve this problem, such as forcing the 
compound back to a racemic mixture so that the process can be repeated to obtain more of the 
desired enantiomer.14-15   
1.5 Asymmetric Synthesis 
Asymmetric synthesis involves the preparation of a substance with one or more chiral centres, 
however in a fashion that regulates the absolute stereochemistry of these centres to a single 
desired configuration.  There are several approaches that can be undertaken which fall under this 
strategy: 
Substrate-Controlled  
The starting material possesses both a prochiral site and a sterogenic centre.  Chiral induction is 
said to be substrate controlled when conversion of the prochiral centre to a chiral centre is 
influenced by the existing chiral centre either by steric effects, or by aiding in the chiral inducing 
reaction. Figure 2 shows the “Active” and “Passive” pathways for substrate controlled 
asymmetric synthesis.  As it is seen, passage is said to be active when the chiral component of 
the substrate takes part in the transition state or intermediate formation step, in turn influencing 
the stereochemical outcome of the reaction.  During the epoxidation of the unsaturated 
cyclopentane alcohol, a hydrogen atom is shared between the alcohol group and the m-
chloroperbenzioc acid (m-CPBA) epoxidation reagent (shown in box).  The pathyway is said to 
be passive if the existing chiral centre of the substrate does not partake in the formation or 
destruction of the transition state or intermediate species.  However, only acts to mediate the 
geometry of how the another molecule or substrate itself can interact with one another (steric 
argument).  This is illustrated in the passive manor in which the stereochemically defined methyl 
group of the cyclic pentanone influences the means of attack of the Grignard reagent (PhMgBr).  
Since the phenyl group is large, it is easier to attack trans to the methyl group and hence the 


























Figure 2: Substrate controlled asymmetric synthesis 
Auxiliary-Controlled  
A chiral auxiliary is attached to the molecule; the auxiliary is enantiomerically pure and serves 
to assist in the chiral inducing reaction.  The auxiliary is then removed after the reaction or at a 
later stage of the synthesis.1, 20-25  From Figure 3, the cyclic compound (red), which has an 
existing chiral centre of known stereochemistry is used to build another molecule.  At a crucial 
step of the synthesis, the existing chiral centre on the auxiliary molecule influences the 
sterochemical outcome of the conjugate addition reaction using benzylbromide and 
lithiumdiisopropylamide (LDA).  After the auxiliary molecule has achieved its purpose, it can 
subsequently be removed to generate either the target molecule or one of the building blocks.  In 
the example the aldehyde (blue) is generated in 95 % enatiomeric excess (ee) and the auxiliary is 




























Figure 3: Auxiliary controlled asymetric synthesis 
Reagent-Controlled  
The reagent used to introduce chirality to the substrate is itself chiral, and therefore chirality in 
this instance is said to be reagent controlled.1, 28-29  This method is expensive and impractical if 
the reagents are consumed during the reaction.  An example of this demonstrated in Figure 4, 
where an aldehyde undergoes a Corey-Chaykovsky transformation to an epoxide.  Using the 
chiral (+)-ylide, the authors were able to achieve up to 99 % ee in some cases.  The is converted 


















Figure 4: Reagent controlled epoxidation of aldehydes with sulphur ylides30  
Catalyst Controlled  
A chiral catalyst with known absolute stereochemistry is used in small quantity, to convert the 
achiral substrate to a chiral one.1, 28, 31-33  
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1.6 Asymmetric Catalysis  
These can be grouped into three main classes, namely; biocatalysis, organocatalysis, and metal 
ligand complexes as catalysts: 
Biocatalysts  
This approach uses naturally occurring enzymes and proteins to carry out asymmetric 
transformations on unnatural substrates.  Because the catalyst is derived from nature, selectivity 
is high (>95 %), however this method is not without its drawbacks.  Reaction rates are readily 
slow, the reaction conditions for the catalyst to operate are stringent and obtaining sufficient 
quantities of the catalyst is difficult.15, 34-36  The enzymes are also in most cases very specific 
with the result that a narrow range of substrates only can be used.  The field is still being 
developed and new methods are appearing in literature, albeit at a relative slow pace.  The 
selective hydrolysis of N-acetylated amino acids using an enzyme found in a hog’s kidney 

















(R)-N-acetylalanine (S)-N-acetylalanine (R)-N-acetylalanine (S)-alanine  
Figure 5: Selective deacetylation of racemic acetylalanine: an example of biocatalysis 
Organocatalysts  
In this approach the catalytic process is completely controlled by the action of a chiral organic 
compound. This has become an attractive area of research with many recent publications and 
reviews detailing the scope of these types of catalysts.  Some of the drawbacks are the high 
catalyst loading and often the reaction times are over a period of several days.  However, despite 
these shortcomings the use of organic molecules over expensive metal catalysts has received 
much attention and is certainly an important field of research.33, 37-40  In many was 
organocatalysis mimics a reagent controlled approach, where the transformation and process is 
influenced by the two.  However, the fundamental difference between a reagent controlled and 
organocatalytised reaction, is that the organocatalyst is regenerated after partaking and is free to 
repeat the process, whereas the reagent is not.  
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Metal-Ligand Complexes as Catalysts   
This approach employs both a metallic and an organic species to catalyse the reaction 
transforming the achiral substrate to a chiral product with preference to a particular enantiomeric 
form.1, 9  Contrary to many organocatalytic reactions, metal-ligand catalysts typically require 
only minuscule molecular loading, the reactions can be fast and the catalysts in some cases 
recoverable.  Some of the drawbacks are the use of expensive and rare metals such as ruthenium, 
rhodium and iridium.1, 41-45  
Metal-chiral ligand complexes and their ability to enantioselectively catalyse reactions that 
transform an achiral substrate to a chiral product is an integral part of this work.  Therefore this 
subject will be discussed with relevance to the project within proceeding sections.     
1.7 Tetrahydroisoquinoline Compounds 
The tetrahydroisoquinoline (TIQ) skeleton provides useful a scaffold that has found applications 
in a diverse range of chemistry.  The basic structure of the 1,2,3,4-tetrahydroisoquinoline 9 is 
shown.  A six membered heterocyclic ring fused to an aromatic species are the basic features for 






Most of the earlier exploitations of the TIQ framework were directed towards pharmaceutical 
applications.46-53  Interest in their activity as antiparkinson‘s disease drugs i.e. Nomifensine 10, 
was noticed in the 70’s.54  One very popular example of a TIQ based drug is Praziquantel 11, an 
anthelmintic which is used for the treatment of human schistosomiasis (bilharzias).55  There are 













Recently, TIQ’s have also been found to act as ligands in a number of asymmetric reactions.57-61  
Basavaiah et al. (2009) demonstrated a TIQ oxazaborolidine 12, similar to the Corey-Bukshi-
Shibata (CBS) catalyst 91, for the reduction of prochiral ketones.59, 62  The catalyst was able to 
reduce the substrates to the alcohol products in high yields (> 90 %), but in poor to good 
enantiomeric excess (19 – 91 %).  Another catalyst, an aminophosphine-oxazoline 13 was used 
by Blanc et al. to carry out asymmetric allylic alkylation reactions.  The catalyst was able to 
deliver the chiral products in quantitative yields and in good enantioselectivity (89 – 93 % ee).57  
Our group has recently reported the use of the TIQ amino alcohol 14 derivative for asymmetric 
transfer hydrogenation of prochiral ketones with high reaction rates (< 60 minutes) and moderate 
to good selectivities (65 – 94 % ee).61  Our group reported the activity of several 3- and 1,3-
substituted TIQ amino alcohol ligands.  The investigation revealed ligand 14a (3-substituted) to 
possess poor activity (28 % conv.) with poor selectivity (35 % ee) for ATH of some aromatic 
ketones.  Ligand 14b was found to have no activity.  In the case of the 1,3-substituted TIQ 
ligands, the cis isomer 14c was found to give good conversion (80 %) but as a racemic mixture.  
However, the other derivative 14d was found to have good activity (94 % conv.) and excellent 






























This project follows on from our recently published work with the reduction of prochiral 
ketones, using instead chiral TIQ diamine donors as ligands for asymmetric transfer 
hydrogenation reactions.    
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1.8 Scope of Investigation Pertaining to Asymmetric Catalysis 
This project is focused towards utilizing novel 3- and 1,3-substituted N,N donor 1,2,3,4-
tetrahydroisoquinoline (TIQ) compounds for asymmetric transfer hydrogenation (ATH) of 
acetophenone.  Many TIQ compounds are prepared from precursors with existing chirality such 
as phenylalanine and dihydroxyphenylalanine (L-DOPA) making chirality appendable on the 
TIQ backbone.63  Given the versatility in tethering the TIQ structure and the rigidity provided by 
the backbone, it holds the potential to be a useful ligand in asymmetric transfer hydrogenation 
reactions.  Figure 6 represents the 3-substituted 15 and 1,3-substituted 16 TIQ skeletons that 





















Figure 6: TIQ backbones used in this study 
1.9 Asymmetric Transfer Hydrogenation (ATH) 
One of the first chemists to notice that hydrogen can be supplied from another source other than 
hydrogen gas was Knoevenagel64-65 in 1903, when he found that in the presence of palladium 
black (elemental palladium), dimethyl 1,4-dihydroterephthalate (17) was converted to dimethyl 
terephthalate (18).  This irreversible process inspired thoughts of a safe and environmentally 
benign hydrogen fuel.  Braude et al. in 1952, applied this observation to reduce ethylene and 







17 18  
ATH was first inspired by the Meerwein-Ponndorf-Verley reduction, discovered in 1924 by 
Meerwein et al.  The reaction involves the reduction of aldehydes and ketones with aluminium 
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isopropoxide in isopropanol (IPA), as shown in Figure 7.67  The hydrogen source (HS) is IPA, 
upon which the aluminium isopropoxide facilitates the hydride transfer from the IPA to the 
substrate.  Since the discovery, there have been many recent publications increasing the scope of 

















Figure 7: Meerwein-Ponndorf-Verley reaction 71 
Originally the honours go to Willy Marckwald in 1904, for identifying that catalysis lent itself to 
asymmetric control.72  Marckwald demonstrated the enantioselective decarboxylation of 2-ethyl-
2-methylmalonic acid to 2-methylbutanoic acid using the alkaloid brucine.73  William Knowles 
and Ryoji Noyori have pioneered and contributed significantly to the field of asymmetric 
transfer hydrogenation over the past two decades.  Knowles was the first to introduce 
asymmetric hydrogenation on an industrial scale, with the enantioselective reduction of a 
precursor to L-DOPA, an anti-Parkinsons drug.73  These advances have lead to increased 
investigations into the scope of ATH reactions.74   
An accepted mechanism for ATH is represented in Figure 8 using the (1S,2S)-N-(p-
toluenesulfony1)-1,2-diphenylethylenediamine (1S,2S-Ts-DPEN) as a ligand+.74-77  The ligand 
first coordinates to the ruthenium metal precursor to form 19.  Available base removes a proton 
from the amine and a chloride from the Ru centre, HCl is liberated and the unstable 16 electron 
species 20 is generated.  A molecule of IPA 21 is attacked by 20 and a hydride is transferred to 
the metal and a proton to the amine (shown by 22).  The loss of the hydride leads to oxidation of 
the IPA forming acetone and rendering the metal hydride 23.  The hydride species 23 reacts with 
the prochiral ketone (acetophenone) 24 as shown by 25, where the hydrides are transferred to the 
substrate along with chiral information from the catalyst.  After the transfer is complete the 
alcohol product (1-phenylethanol) 26 is released and the 16 electron species 20 is reformed.  Not 
only in this instance, but on any occasion when IPA is employed as the hydrogen source the 
reaction is subject to reversibility.   
                                               























































Figure 8: Pathway of ATH78, * 
The addition of a base was found to accelerate reaction rates and increase turnover numbers 
(TON) of these reactions.  To contend with, an earlier discovery by Parnes et al. in 1960 
revealed that an azeotropic mixture of formic acid and triethylamine (TEAF) could also be used 
as a source of hydrogen, but at the time was used with only moderate success.79  Fujii et al. in 
1996 found the advantages of TEAF in place of the IPA HS with their catalyst, obtaining 
quantitative yields and optical purities of greater than 90 %, demonstrating TEAF to be an 
attractive alternative.78 The mechanism for TEAF is similar to that of the IPA with the exception 
that an irreversible oxidation to carbon dioxide occurs upon hydride removal from the formic 
                                               
* The mechanism is adapted from reference 78, and is widely accepted in the literature.  It is noted that the 
stereochemical outcome of the reaction going from transition state 25 to compound 26 appears to be wrong, and that 
the other enantiomer should have been produced given the representation.       
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acid.  Although a useful alternative, ATH reactions using TEAF often require longer reaction 
times than those with IPA.78  
1.10 Substrates Covered by ATH 
Asymmetric transfer hydrogenation has been applied to a diverse range of substrates which can 
be categorised into three groups; ketones, α,β-unsaturated compounds and imines.  It should be 
noted that the catalyst designs and choice of metal precursors used will be outlined in more 
detail in Chapter 2.    
Ketones  
Prochiral ketones have been the most extensively studied substrates for ATH, more specifically 
aromatic ketones such as acetophenone (25).80-81 Most of these aromatic and some aliphatic 
ketones are reduced to the chiral alcohol products in excellent yield and optical purity.78, 82-85 
These simple ketones are typically the bench mark when screening any new catalysts for activity 
in ATH.  Figure 9 shows some of the more “exotic” and difficult ketone substrates that have 
been reduced with at least a significant degree of success in ATH.74, 86   
Watanabe et al. in 2002, investigated ATH of α-functionalised-acetophenones such as 27, the 
(S,S)-TsDPEN ligand was employed with a [Ru(p-cymene)Cl2]2 metal precursor (MP) and TEAF 
HS.87  The catalyst produced the chiral alcohols in enantiomeric excess > 90 % (ee).  Subsequent 
reduction of azide, nitro and cyano groups, using palladium on carbon or borane 
dimethylsulphide complex gave the amino alcohols without change in optical purity.74, 87  Later 
work by Hamada et al. in 2004 focused more on the ATH of α-chloroacetophenone derivatives 
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Figure 9: Ketone substrates used in ATH 
With the (R,R)-TsDPEN, [RhCp*Cl]2 MP and TEAF HS, Hamada and co-workers obtained 
selectivities in the region of 88 % to 97 % ee with good conversion.  The study revealed the 
catalyst to be insensitive to the functional group, or its location on the aromatic ring i.e. o, p or 
m-Cl or OMe.74, 88  Using a similar system as mentioned for Hamada’s work, Okano et al. 
illustrated that pyridyl ketone 29 derivatives are also amenable to ATH when a ruthenium MP 
was employed.89  Benzils 30 and ketoesters 31 and 32 have also been also been subjected to 
ATH reactions.90-92 
Olefins 
Based on all recognized and accepted mechanisms proposed for ATH, it is not unreasonable to 
say that the reduction of non-activated olefins is challenging.  Without a functional group to 
activate the olefin the hydrogen transfer process is difficult.93-95  Olefins of this nature are partial 
to other forms of transfer hydrogenation as mentioned earlier i.e. Braude.66  There are many 
activated olefin compounds that lend themselves more susceptible to ATH, these are naturally 
the -unsaturated olefins.     
Xue and co-workers investigated the extent of ATH with α,β-unsaturated ketones, esters, nitro 
and cyano substrates shown in Figure 10. 96-97  For unsaturated ketones it was observed that in 
some cases three possible products could be obtained; either the C=C group was reduced, 
leaving the C=O intact (i), alternatively, only the C=O group was reduced and not the C=C (ii) 
or both the C=O and C=C were reduced (iii).  They were able to show that for derivatives 33a - 
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d, the reduction favoured the formation of (ii), this seemed to hold true so long as the R1 and R2 
groups were either both methyl i.e. 33b - d, or alternatively R2 was methyl substituted while R1 
was hydrogen.  When R2 was then changed to an aromatic group, and R1 left as a hydrogen 3e, 
the reduction gave both (i) and (iii) products.  Further, changing R1 to a ketone or ester 33f - g, 
favoured formation of (i) type products.  Only moderate enantioselectivities of 39 % - 76 % ee 
for 33a - d were obtained.97  The authors inferred that the change from C=O to C=C reduction 
through 33a - g, arises from an increase of polarisation when a more electron withdrawing group 














a: Ar = Ph, R1 = H, R2 = Me
b: Ar = Ph, R1 = R2 = Me
c: Ar = p -NO2C6H4, R1 = R2 = Me
d: Ar = p -MeOC6H4, R1 = R2 = Me
e: Ar = Ph, R1 = H, R2 = Ph
f: Ar = Ph, R1 = MeCO, R2 = Me
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Figure 10: -Unsaturated compounds tested in ATH 
The same authors attempted ATH on olefins activated by other functional groups, compounds 
35 - 40.  These substrates were reduced in good yield but unfortunately poor selectivity, ranging 
from 0 % to 54 % ee.97 
Imines 
Imines are important intermediates in organic synthesis for the preparation of amines. In 
addition to this they loan themselves amenable to asymmetric reduction.  Undoubtedly they are 
an invaluable tool for the preparation of chiral amine based drugs, hence they have also been 
extensively studied substrates in the ATH field.77, 98-105   
In 1996 Uematsu reported the enantioselective reduction of imines.  The authors used imine 
containing tetrahydroisoquinoline (TIQ) and some other imine containing compounds as 
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substrates for ATH with a ruthenium catalyst.106  As shown in Figure 11, substrates with varying 
R-groups were reduced with high enantioselectivity ranging from 84 % to 95 % ee.  It was also 
found that a TEAF HS was necessary for ATH of imines while IPA was not a feasible donor as 
determined by deuterium exchange studies.77, 106  
The same group reported the reduction of tryptophan TIQ derivatives 41 and 42 in good 
enantioselectivity of up to 97 % ee.  Less complex imines 43 and 44 were also reduced with ee’s 
of 77 % and 89 % respectively.106  Heteroatomic aromatic substrates possessing imine groups 
were also investigated i.e. compound 45, 46  and 47, still employing the same catalyst the 
reduced products were obtained in good enantiomeric excess of 85 % and 88 % respectively in 
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Figure 11: Imine substrates explored for amenability to ATH 
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Chapter 2 will briefly discuss some of the most successful catalysts developed for ATH.  The 
logic and design behind our ligands will also be explained.  The synthesis and testing will follow 




Chapter 2  
2.1 Ligands for ATH Reactions  
It has been shown in the literature that amine and diamine based ligands are useful auxiliaries in 
various asymmetric catalytic reactions.85, 107-111  Noyori et al. tested a variety of simple amino 
alcohols and diamines with a ruthenium metal precursor (MP) using an isopropanol (IPA) 
hydrogen source (HS) and a KOH co-catalyst for the reduction of acetophenone (see Figure 12) 
and other ketones.83, 85  It was noted that a two-carbon bridge between the donors (heteroatoms) 
formed the ideal metal chelator, and that unlike the amino alcohols, the diamines required one of 
the amines to be functionalized with an electron withdrawing group such as a p-toluenesulfonyl 
(Ts).  Hence (1S,2S)-N-(p-toluenesulfony1)-1,2-diphenylethylenediamine (Ts-DPEN) 50 was 
found to have a good catalytic performance in ATH when coupled with a ruthenium MP.85 This 
catalyst was able to convert acetophenone 24 to (S)-1-phenylethanol 26 in 97 % ee (Figure 12) 






24 26  
Figure 12: Reduction of acetophenone using the Ts-DPEN ligand and a ruthenium metal precursor 
There have been many successful ligands developed for ATH reactions, the structures of some 
are shown by compounds 50 – 57.  Noyori et al. in 1995 shortly after their use of TsDPEN as a 
ligand for ATH, demonstrated that the amino alcohol 51 had a similar high performance.82  With 
a [RuCl2(C6Me6)]2 precursor in IPA the ligand performed equally as well as 50 producing the (S)-
1-phenylethanol product in high enantiomeric excess (ee).  However the reaction times with 51 
were greatly reduced in comparison to 50.82, 84-85  Puntener et al. who worked on chiral ferrocene 
compounds as ligands for asymmetric catalysis, introduced the diamine 52.112  This ligand 
coupled with [RuCl2(p-cymene)]2 in IPA113-114 gave moderate enantioselectivity in favour of the 
(R)-isomer.  Following Noyori’s monotosylated diamine design, Knochel also explored 
commercially available chiral cyclohexyl diamine derivatives for ATH.  He showed that 
monotosylation of one of the amine groups to give 53, and utilizing the same [RuCl2(p-
cymene)]2  MP as before with a TEAF HS rapidly rendered (R)-26 in excellent ee.112  Schiffers et 
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al. used this simple and easily accessible backbone as an auxiliary for the amino alcohol 54.115  
Similar to the case of Noyori, both the amino alcohol (51 vs 54) and the diamine (50 vs 53)  
versions behaved analogously in terms of selectivity.  However, contrast in rapid conversion was 
merely attributed to the TEAF HS over the IPA used for Noyori’s diamine.  Another economical 
design by Palmer et al. also employed an amino alcohol 55 using an indanol as a rigid 
scaffolding for ATH.116  Moderate conversions and high ee’s with the [RuCl2(p-cymene)]2 and 
IPA HS has added this ligand as another tool for ATH of prochiral ketones.  Thereafter Alanso 
et al. in 2000 used the bicycle 56, and was able to obtain good selectivity for the reduction of 
ketones with ee’s around 90 %.117  In 2001 Rhyoo used an amino amide 57, derived from 
proline, as a source of chirality.  They reported that in aqueous media high conversions were 
achieved with moderate selectivity using a formate HS.118   
Table 1 represents the results obtained for ligands (50-57) in the ATH of acetophenone.  There 


























Other studies have attempted to optimise the performance of these catalysts, by varying sterics, 
electronics and the solubility properties.112, 115-116, 118, 125-127  Development of the triethylamine: 
formic acid azeotrope (TEAF), and more recently, formate salts in aqueous media have also 
broadened the scope for activity and selectivity.78, 118  The aqueous systems show promise and in 
many cases enhanced overall performance has been observed in the presence of water.  A 
rigorous screening of these variables is necessary to discover the potential of any new ligand.  
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Table 1: Table of results for ATH of acetophenone for some successful diamine and amino alcohol ligands 
Ligand HS Temp Time /h Metal % Conv. % ee Isomer 
50 IPA RT 15 [RuCl2(mesitylene)]2 95 97 S82 
51 IPA 28 1 [RuCl2(C6Me6)]2 94 92 S82, 84-85 
52 IPA 22 0.5 [RuCl2(p-cymene)]2 98 71 R112-114 
53 TEAF 30 24 [RuCl2(p-cymene)]2 99 94 R112 
54 IPA RT 1 [RuCl2(p-cymene)]2 94 92 S115 
55 IPA RT 1.5 [RuCl2(p-cymene)]2 70 91 S116 
56 IPA RT 0.7 [RuCl2(p-cymene)]2 97 94 S117 
57 NaCO2H 30 4 [RuCl2(p-cymene)]2 99.4 61 R118 
 
Herein we report a systematic study of novel diamine ligands possessing the 
tetrahydroisoquinoline (TIQ) as a rigid and tunable chiral backbone for pre-catalysts to the 
asymmetric reduction of acetophenone. 
2.2 Synthesis of TIQ Diamine Ligands  
It should be noted that the syntheses of all 3- and 1,3-substituted 1,2,3,4-tetrahydroisoquinoline 
(TIQ) diamine ligands originated from common starting materials prepared as shown in Scheme 
1 and 2.  The 3-substituted TIQ is prepared by an acid catalysed Pictet-Spengler reaction using 
hydrobromic acid (HBr).  The imine formed by condensation of the formaldehyde and the amine 
group of the (S)-phenylalanine 58 then undergoes nucleophilic attack by the aromatic ring to 









40 - 80 °C, 4 Hrs
58 59  
Scheme 1: Synthesis of 3-substituted TIQ precursor 
Preparation of the 1,3-substituted 1,2,3,4-tetrahydroisoquinoline precursors involved a slightly 
more demanding synthesis.  This was due to generation of a second chiral centre at the 1-
position.  The starting material L-DOPA (dihydroxyphenylalanine) 60 was treated with 
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potassium carbonate (K2CO3) in a 50:50 mixture ethanol:water and chilled in an ice bath.  











































Scheme 2: Synthesis of 1,3-substituted TIQ precursor 
After three hours the solid precipitate formed is filtered and carefully washed with a chilled 
mixture of 50:50 ethanol:water, ensuring that only the insoluble trans isomer 61 was obtained.  
Protection of the nitrogen with a benzyloxycarbonyl (Cbz) group under standard Schotten-
Bauman conditions yielded 62.  It was desirable to block the phenolic hydroxy groups by 
methylation using dimethyl sulphate to form 63 allowing for subsequent synthesis.  Removal of 
the Cbz by treatment of 63 with Pd/C and H2 gas gave the desired precursor 64.61, 63   
2.3 Preparation of Mono-Tosylated TIQ Compounds 
As it has been shown in the literature, monotosylated diamines serve as effective ligands in 
ATH; therefore this design served as a starting point to the synthesis of our diamine TIQ ligands.  
Standard protection of 59 (Scheme 3) with Cbz was carried out to block the nitrogen forming 
65.129  Two synthetic procedures to obtain the amide were explored:  i) acid chloride formation 
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from the acid followed by treatment with a solution of ammonia in chloroform, ii) activation of 
the acid with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide) hydrochloride (EDC.HCl) and 
hydroxybenzotriazole (HOBt) then substitution by NH3 sourced from ammonium chloride 
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Scheme 3: Synthesis of amide precursor to primary, secondary diamine ligand 
The proposed compound was necessary to the investigation of TIQ diamines as ligands for 
ATH, therefore alternative synthetic approaches were sought.  A procedure was found to prepare 
the amide without protection of the amine.56  Precursor 59 (Scheme 4) is converted to the ester; 
the authors did so by bubbling HCl through a solution of 59 in MeOH for 24 hours.  However 
two alternative esterification methods were carried out in an effort to shorten this step.  First 59 
was refluxed in MeOH with a catalytic amount of sulfuric acid for three hours and second 59 in 
MeOH was treated with thionyl chloride and stirred at room temperature for three hours.  The 
thionyl chloride method was chosen as the preferred route because the ester was obtained in high 
yield as the HCl salt of the product 67, necessary for the next reaction.  The amide 68 was 
rendered by conversion of the ester to amide from exposure of 67 with a large excess of 25 % 
ammonium hydroxide, and required no further purification.  Amine protection of 68 with Cbz to 
form 66, meant that special reduction conditions were required to convert the amide to an amine 
without cleavage of the Cbz group.  The use of a more robust benzyl protection was attempted, 
however opening at the 1- and 2-positions was observed with long exposure to Pd/C with H2 
gas.  Therefore a mixture of acetic acid and sodium borohydride in dioxane was engaged which 
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provided the Cbz protected TIQ primary amine 69.  Yields for this reduction were extremely 
low and despite addition of excess reducing agent and extended periods under reflux conditions, 
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Scheme 4: Synthetic route to 3-substituted Ts-diamine 
Several procedures were attempted to add the tosyl group (Ts) onto 69; these are shown in 
Scheme 5.  Both tosylation by sodium hydroxide in water and in neat pyridine proved 
ineffective.  When carried out in DCM with TEA as the base the reaction proceeded to form the 
Ts product 70.  Removal of the Cbz group provided the desired mono tosylated diamine 









































Scheme 5: Synthetic routes used to add Ts group onto 3-substituted TIQ 
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Preparation of 3-substituted 71 involved many synthetic steps, synthesis of a 1,3-substituted TIQ 
derivative would require several more steps.  Therefore it did not seem feasible to prepare a 1,3-
substituted TIQ version for use as a ligand in ATH.   
2.4 Preparation of Primary, Secondary Amine TIQ Compounds 
Preparation of the 3-substituted TIQ 72 shared similar reactions steps to 71, as shown in Scheme 
6.  Lithium aluminum hydride (LiAlH4) was employed as the reducing agent, which 
unfortunately required a long reaction time (96 hours) under reflux conditions to afford the 
amine 72 in low yield.  Despite numerous attempts to reproduce the yields and reaction times (3 
hours) reported for this compound in literature, our efforts were unsucessful.56, 131  The polar 
nature of 72 made purification by gravity chromatography using silica-gel difficult.  Semi-
preparative liquid chromatography using a C18 stationary phase was attempted with little 
success in obtaining the compound in good purity.  Finally, it was discovered that precipitation 











Scheme 6: Preparation of primary, secondary amine ligand 72 
The same procedure was utilized in an effort to obtain the 1,3-substituted diamine TIQ 74 
(Scheme 7).  However, epimerisation at the 1-position occurred whilst reducing 73. This is 
typical of dibenzylic systems rendering the proton at that 1 position moderately labile when 


























74 75  
Scheme 7: Preparation of 1,3-substituted TIQ primary, secondary amine ligand 
Attempts to separate the diastereomers were unsuccessful, as well as achieving adequate 
purification for characterization.  Therefore this ligand was abandoned and was not tested for 
activity in ATH.  
2.5 Synthesis of Secondary, Secondary Amines 
The secondary, secondary amine system was employed as a means of introducing steric bulk to 
the molecule at the 3-position.  The respective amines were coupled to the acid 65 via a 
condensation reaction using EDC.HCl, HOBt and a catalytic amount of DMAP to form the 
corresponding amides 76a - g.  Removal of the Cbz group with Pd/C and H2 gas at one 
atmosphere afforded 77a - g, which were then treated with LiAlH4 for 96 hours in THF under 
reflux conditions to form the desired secondary amine compounds 78a - g.  In situ removal of 
the Cbz group with LiAlH4 was attempted, but other side products were formed, therefore it was 







































21 %31 %57 %46 %15 %
76 %72 %80 %85 %88 %92 %77 %
89 %78 %71 %75 %83 %85 %
30 % 35 %  
Scheme 8: Preparation of secondary amines 
This scheme was successful in delivering all of the final ligands (78a-g). 
2.6 Preparation of 1,3-Substituted TIQ Secondary, Secondary Amine Ligand  
The synthesis of the 1,3 substituted diamine version did not follow that of the 3-substituted 
version (Scheme 9) this was due to racemisation that was observed as mentioned for the 
preparation of 74.  Therefore another strategy employing the addition of a leaving group at the 
3-position and hence a substitution reaction using benzylamine could be carried out.  Initially the 
alcohol was prepared by reduction of 64 to give the amino alcohol 14d which could then be Cbz 
protected to give 79.  The protected alcohol served as a precursor for addition of the leaving 
groups, the first of which was an attempted replacement with a chloride to give 80.  However 
this was unsuccessful and cyclisation rendering 82 occurred.  A second attempt, this time adding 
a tosyl group to 79 to form 81 was tried, but again cyclisation occurred to form 82.  This was 
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tracked using low resolution mass spectrometry.  It was apparent that an alternative means to 
prepare the 1,3-substituted TIQ was necessary. 
LiAlH4
THF






























Scheme 9: Attempted synthesis of 1,3-benzyl sustituted TIQ ligand 
Another route (Scheme 10) which places a phthalimide group 83 onto 79 using the Mitsonubu 
reaction132 with diethylazidodicarboxylate (DEAD) to produce 84 was tried.  This would 
produce the primary amine 85 upon removal of the phthalimide protection.  In turn, reductive 
amination with benzaldehyde could be used to insert the benzyl group to form 86 which would 
require only a deprotection step to form the product.  However the synthesis did not proceed 
beyond 84 due to problems incurred during the phthalimide deprotection step.  
After that attempt the same strategy (Scheme 4) for the conversion of 66 to 69 was used to 
convert the Cbz-protected amide to the Cbz-protected amine.  However the same problems of 
long reaction times and low yields were encountered and not enough could be obtained to carry 
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out the two additional steps to achieve the desired benzyl 1,3-substituted TIQ diamine ligand.  































Scheme 10: Attempted synthesis of 1,3-benzyl substituted TIQ ligand 
Eventually, preparation of diamine 88 (Scheme 11) was carried out by oxidation of the alcohol 
79 with pyridinium chlorochromate (PCC) to produce 87.  A reductive amination using 
benzylamine (Bn-NH2) to form the imine with subsequent reduction to the amine using sodium 
cyanoborohydride (NaCNBH4) producing 86.  Final and selective deprotection of the Cbz group 
was closely monitored to insure that both the benzyl and the Cbz group were not removed to 

































Scheme 11:  Preparation of 1,3-substituted TIQ ligand 88 
An alternative route was attempted for preparation of the 1,3-substituted amine from the 
corresponding amide.  This method involved the use of borane (BH3) in tetrahydrofuran (THF), 
BH3 is able to reduce amides and acids in a different manner to that of LiAlH4.  The BH3 is mild 
relative to LiAlH4 with regards to its basic nature (Lewis base) and this appeared to present a 
probable solution.19  However, when the reduction was carried out on the amide precursor 89 











Scheme 12: Attempted reduction of amide precursor using BH3.THF complex 
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Chapter 3  
3.1 Results & Discussion 
The following ligands were tested for activity in ATH using IPA as the hydrogen source, 
potassium t-butoxide (KOtBu) as the base and the following metal precursors; [Ru(p-
cymene)Cl2]2, [IrCl2(Cp*)]2 and [RhCl2(Cp*)]2.  These conditions were chosen based on those 
employed most commonly in the literature.  The ligands tested in this investigation are 
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Figure 13: Ligands tested for performance in ATH of acetophenone 
The model reaction used in this investigation was the asymmetric transformation of 








Figure 14: Model reaction used in this investigation 
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Key: from here on in, the term “activity” refers to the catalysts ability to convert (conversion) 
acetophenone to 1-phenylethanol.  The term “performance” describes both the catalysts ability 
to convert acetophenone to 1-phenylethanol and its selectivity in doing so.  The terms “good”, 
“poor” and “moderate” are also used extensively in the discussion.  These terms have no fixed 
meaning, but are simply used in relative tense with regard to another catalyst to which it is 
being compared.   
Monotosylated Diamine TIQ Ligand 71 
The monotosylated diamine 71 as the first of the ligands prepared, showed no activity for the 
transformation of acetophenone 24 to 1-phenylethanol 26 using any of the metals precursors.     
Primary, Secondary Amine Ligand 72 
Ligand 72 possessing a primary amine extending from the 3-position and a secondary amine 
located on the TIQ backbone at the 2-position demonstrated little activity for ATH of 
acetophenone when [IrCl2(Cp*)]2 was used as the metal precursor.  The reduction was 
monitored over a 24 hour period and was found to reach a maximum conversion of 10 % with 
no enantioselectivity.   
Secondary, Secondary Amine Ligands 78a-g & 88 
Ligands 71 and 72 share a similar design to Noyori’s diamine and monotosylated diamine.  
However, unlike Noyori's which possess a di-primary or primary and tosylated secondary amine, 
our ligands have a cyclic secondary amine in a six-membered ring.  Ligand 71 was found to be 
completely inactive, whilst 72 demonstrated only poor activity when using an Iridium MP.  
Therefore, as our system differs from that of Noyori’s, as expected we needed to perform 
structural modifications in order to achieve activity.  The secondary amine on the TIQ back bone 
is “fixed”; therefore only the 3-position remained free to functionalise.  In order to study the 
effect of both steric and electronic influence on activity, several secondary amine derivatives 
were prepared (78a – g).    
Ligands 78a and b possessing a methyl and isopropyl group respectively are inherently both 
electron-donating groups differing only in size from one another.  The results for the ATH of 
acetophenone for these ligands (Table 2) revealed 78a to have no activity at all, whilst 78b was 
moderately active, giving a conversion of 67 % to the (S)-1-phenylethanol product.  As a result 
of this positive response in activity from the larger isopropyl group (78b), a more bulky 78c was 
prepared giving an aniline group.  78c possessed no activity, demonstrating that there must be a 
balance between the steric and electronic behaviour of the substituent on the nitrogen.   
32 
 
To test this, ligand 78d was synthesised.   78d possessing a benzyl group, is poorly electron-
withdrawing , can be considered to be nearly neutral in its electronic contribution.  With ligand 
78d an 81 % conversion of acetophenone to (S)-1-phenylethanol was obtained.  This confirmed 
the view that a balance between the sterics and electronics must be obtained for there to be 
activity.  To further investigate the extent of this idea, a dibenzyl substituent (78e) was 
synthesised for comparison to ligand 78d.  The dibenzyl is only slightly more electron-releasing 
than a benzyl group, so its electronic difference is not significant.  However, sterically the two 
substituents differ greatly.  It was observed that ligand 78e shows poor activity with a 
conversion of 22 % to (S)-1-phenylethanol, a considerable change from the 81 % conversion 
obtained for 78d.   
As discussed earlier, it was noted that the isopropyl group is slightly bulkier than the benzyl, 
however, not much activity is lost on going from the benzyl to the isopropyl, and in addition, a 
slight gain in selectivity is observed.  Therefore we decided to add a chiral substituent to the 
nitrogen in order to achieve better selectivity.  Based on the comparisons and conclusions 
drawn, it was decided that chiral phenylmethyl groups should be used (ligands 78f and g).  The 
electronic influence of the methyl (electron donating) is counteracted by that of the phenyl group 
(slightly electron withdrawing) and vice versa.  Therefore the electronic character of the group 
lies between that of an isopropyl and a benzyl moiety.  The phenylmethyl substituent is slightly 
larger than both the isopropyl and the benzyl and therefore a slight drop in activity was 
anticipated.  From the results it was shown that both 78f and g gave poor activities, 24 % and 5.5 
% respectively.  The difference in activity of the chiral isomers is likely to be due to the 
orientation i.e. cis and trans relative to the pre-existing chiral centre on the TIQ, when 
complexed to the metal.  This is supported by the choice of isomer for each ligand (R)-isomer for 
78f and (S)-isomer for 78g.  The anticipated increase in selectivity was observed for ligand 78f, 
with an enantiomeric excess of 77 % for the (R)-isomer.  The same was not true for the other 
chiral phenylmethyl isomer 78g, which had an enantiomeric excess of 51 % for the (S)-isomer. 
Previously our group has reported the activity of some 3- and 1,3-substituted TIQ amino alcohol 
ligands i.e. ligand 14d.  This prompted us, having screened a variety of 3-substituted diamines, 
to investigate whether adding a phenyl ring to the 1-position would have any value in increasing 
the selectivity.  Therefore, a benzyl substituent was added to the 3-position yielding ligand 88.  
Surprisingly, the diamine mimic of 14d did not demonstrate any activity at all.   
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Table 2:  Asymmetric transfer hydrogenation of acetophenone by ligand 78a-g & 88 rhodium complexes 
Entry Ligand % Conv. % ee Isomer 
1 78a - - - 
2 78b 67 71 S 
3 78c - - - 
4 78d 81 70 S 
5 78e 22 11 S 
6 78f 24 77 R 
7 78g 5.5 51 S 
8 88 - - - 
All reactions were carried out at 25 °C.   
IPA was used as the solvent when employed as the HS along with t-BuOK as the base.  Testing was carried out 
using a substrate to catalyst ratio (S/C) of 100.  
Measured by GC with chiral capillary column β-DEX™ 120. 
 
In the case of the secondary amine ligands, a certain amount of water was required in order for 
selectivity to be observed in the ATH reaction.  This is not uncommon, and as stated in Chapters 
1 and 2, water is often employed as the reaction solvent.  It has been demonstrated in the 
literature that water has potential to influence the performance of a catalyst in ATH reactions.118, 
121, 125, 136-140  The results in Table 2 reflect the optimised amount of water found using the benzyl 
ligand 78d.  Table 3 presents results regarding the optimised water content.  Adding one 
equivalent of water to the metal complex was found to increase activity relative to no water (27 
%, entry 1).  Progressively increasing the amount of water from 2 to 400 equivalents showed an 
improvement in selectivity (entries 2 – 6).   Thereafter, raising the amount of water to a 1000 
and further to 3000 equivalents a maximum was reached with an optimum of 70 % 
enantioselectivity (entries 7 – 9).  Increasing the amount of water to 50:50 water:IPA (many 
times excess) destroyed the reactivity completely (entry 10).  Since reactivity dropped 
significantly at 3000 equivalents, 1500 equivalents was taken as the best compromise between 
reactivity and selectivity for subsequent testing. 
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Table 3: Results of the effect on the enantioselectivity in varying the water content added to the ATH 
reaction of acetophenone catalysed by the rhodium-78d complex  
Entry Molar eqv H2O Conv. % ee % 
1 1 64 27 
2 2 81 43 
3 10 88 45 
4 100 92 54 
5 200 88 62 
6 400 92 66 
7 1000 94 68 
8 1500 81 70 
9 3000 61 70 
10a 50:50 - - 
All reactions were carried out at 25 °C.   
IPA was used as the solvent when employed as the hydrogen source along with t-BuOK as the base.  Testing was 
carried out using a S/C of 100. 
Measured by GC with chiral capillary column β-DEX™ 120. 
a A 50/50 mixture of water and IPA was used.   
 
Further study of the effect of metal precursor and HS for ligand 78d was carried out (Table 4).  
Entries 1 and 4 show that very little activity is observed when the ATH reaction is performed in 
water using a potassium formate hydrogen source (2 %, entry 1), and no activity with the IPA 
(entry 4) when [Ru(p-cymeme)Cl2]2 is employed as the metal precursor.  The same held for the 
formate hydrogen source with [IrCl2(Cp*)]2 (10 %, entry 2).  However a marked increase in 
activity was observed when the HS was changed to IPA (40 %, entry 5) for the [IrCl2(Cp*)]2 
MP.  Implementing a [RhCl2(Cp*)]2 precursor rendered significant activity with the formate (43 
%, entry 3), but the greatest catalytic activity was seen when the IPA was used instead (90 %, 
entry 6).  The results for the [RhCl2(Cp*)]2 prompted us to investigate whether using a TEAF 
HS could increase the activity.   Unfortunately this proved unsuccessful (entry 7).  Changing 
from the [RhCl2(Cp*)]2 (arene) to the RhPPh3COH (hydride) did not give an improvement on 
the [RhCl2(Cp*)]2 system (10 %, entry 8).  Therefore optimised conditions were found to be 
with the use of [RhCl2(Cp*)]2 precursor and IPA.   
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Table 4: Asymmetric transfer hydrogenation of acetophenone by different hydrogen sources and ligand 78d 
metal complexes 
Entry Metal Complex HS  Conv. %a ee %a Isomer 
1 [Ru(p-cymene)Cl2]2 KCO2H 2 10 R 
2 [IrCl2(Cp*)]2 KCO2H 10 25 R 
3 [RhCl2(Cp*)]2 KCO2H 43 50 R 
4 [Ru(p-cymene)Cl2]2 IPA - - - 
5 [IrCl2(Cp*)]2 IPA 40 - - 
6 [RhCl2(Cp*)]2 IPA 90 - - 
7 [RhCl2(Cp*)]2 TEAF - - - 
8 RhPPh3COH IPA 10 48 R 
All reactions were carried out at 25 °C.  In the case where the hydrogen source is KCO2H the solvent used was 
water.   
IPA was used as the solvent when employed as the hydrogen source along with t-BuOK as the base.  Testing was 
carried out using a S/C of 100. 
a Measured by GC with chiral capillary column β-DEX™ 120. 
In previous work on ATH reactions using amino alcohols by our group, the 3 substituted ligands 
were found to perform poorly.   The 1,3-substituted ligands however, under the same conditions 
gave a range of performance from poor to good.61  In the case of our diamine ligands, a reverse 
scenario was observed.  Several 3-substituted ligands were identified as reasonable catalysts 
namely; 78b, d and f.   
It was also noted from previous investigations of the TIQ amino alcohols, that the ligands 
functioned best under anhydrous conditions.  However, in the diamine system water was crucial 
in order to obtain selectivity.   
In the case of the TIQ amino alcohols ligands, both the [RhCl2(Cp*)]2 and the [Ru(p-
cymeme)Cl2]2 precursors produced very active catalysts when IPA was used as the HS.  
However, the highest selectivity was achieved with the [Ru(p-cymeme)Cl2]2 precursor.  In the 
case of our diamines, [Ru(p-cymeme)Cl2]2 was observed to have poor activity with these ligands 





In our investigation 24 TIQ diamine derivatives were prepared for use as ligands in ATH of 
acetophenone.  Ligand 71 was shown to have no activity for the ATH of acetophenone.  To 
elaborate on this the primary amine derivative, ligand 72 was also prepared to simulate 
ethylenediamine, an active ligand for transfer hydrogenation.  However, this too was 
unsuccessful.  It was inferred to be as a result of the difference in the electronic character of the 
secondary amine at the 2-position of the TIQ as opposed to the primary amine in Noyori’s and 
the ethylenediamine case.  Therefore we decided to change the structure at the position where 
modification was easiest, namely the 3-position.  A series of secondary amines derivatives were 
prepared with substituent's that influenced the electronics and the sterics of and around the 
nitrogen donor, ligands 78a-g.  Several of these ligands were found to be active and selective for 
the ATH of acetophenone (78b, d, e, f and g), whilst others possessed no activity (78a and c).   
We found that 78d (81 % conv.) possessing a benzyl substituent, had the greatest activity, thus it 
seems creating the appropriate balance of sterics and electronics to a greater extent than the 
other substituents.  The highest selectivity achieved was when a phenylmethyl derivative (78f) 
was employed (77 % ee), however, the activity of this ligand was low (24 % conv.).  Our 
structural investigation of the TIQ diamines concluded with a 1-(phenyl) 3-substituted ligand 
(88) that gave no activity.  It was discovered in the case of our active diamine ligands that an 
optimised 1500 equivalents of water was necessary to be added in order for there to be optimum 
enantioselectivity.  The exact role of the water was never ascertained.  Many publications on the 
possible mechanism of water in ATH reactions have appeared and due to the increased scope of 
such an investigation, it was decided to exclude that in the current project.  A range of metal 
precursors were also investigated and [RhCl2(Cp*)]2 was found to be the best for our TIQ 
diamine ligands.   
The ligand with the greatest overall performance was 78d, yielding a conversion of 81 % and an 
enantioselectivity of 70 % ee for the (S)-1-phenylethanol product.  We have successfully studied 
the use of TIQ diamine compounds as ligands for the ATH of acetophenone, and have 
established criteria for the further rational design of this system.   
The investigation also revealed that the N,O-TIQ system differs from the N,N-TIQ ligand in 
several ways; First, the choice of active metal precursor is different, Ruthenium versus 





Chapter 4  
4.1 Experimental 
General 
All reagents and solvents were purchased from Aldrich, Merck and Fluka unless stated 
otherwise.  All NMR analysis was carried out on either a Bruker AVANCE III 400 MHz or 600 
MHz instruments.  Chemical shifts are expressed in ppm and referenced to the TMS signal, 
which the NMR solvents purchased, had been pre-spiked.  Coupling constants are reported in 
Hz.  NMR spectra were obtained at room temperature, except if stated differently.  Thin layer 
chromatography (TLC) was performed using Merck Kieselgel 60 F254.  Crude compounds were 
purified via column chromatography using Silica gel (60–200 mesh except if stated otherwise).  
All solvents were dried using standard procedures from Vogel.130  All IR spectra were recorded 
on a Perkin Elmer spectrum 100 instrument with a universal ATR attachment.  Optical rotations 
were measured on a Perkin Elmer Polarimeter Model 341.  All melting points (MP) are 
uncorrected.  High resolution mass spectrometric data was obtained using a Bruker micrOTOF-
Q II instrument, with a sample concentration of approximately 1 ppm.  All gas chromatography 
(GC) was carried out on an Agilent 6820 with a chiral capillary column, β-DEX™ 120. 
Spectral data are provided for all non novel compounds with appropriate references.  All novel 
compounds were prepared following synthetic strategies and procedures found in literature for 
which the relevant reference has been provided.   
General Procedure for Transfer Hydrogenation of Acetophenone85 
IPA hydrogen source: To an oven-dried Schlenk tube was added the metal precursor (3.0 mg) 
followed by the ligand (4 mol. equivalents) and freshly distilled IPA (5 mL) under a dry argon 
atmosphere.  The mixture was heated to 60 °C and stirred for 20 minutes, after which the 
solution was allowed to cool to ambient temperature.  The desired amount of acetophenone was 
then added (substrate to catalyst - S/C = 100) followed by freshly prepared 0.1 M KOtBu (2 
equivalents to metal) in IPA.  To monitor the reactions, small aliquots were drawn, diluted with 
IPA and then run through a small plug of silica gel to remove any catalyst.  The eluted sample 
was then injected into the GC.   
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IPA hydrogen source in water: The reaction was carried out as reported above with the 
exception that water was added after complexation and just before the addition of acetophenone.  
Monitoring of the progress of the reaction remained the same.   
Formate hydrogen source:118 The metal precursor and ligand were complexed as described 
above.  Water was then added (2 mL), and the reaction mixture heated to 40 °C and stirred for 
30 minutes.  The mixture was then cooled and the acetophenone (S/C = 100) was added 
followed by the potassium formate.  To monitor the reactions, small aliquots were drawn and 
extracted with hexane, which were then used for GC analysis.   
TEAF hydrogen source:78  The metal precursor and ligand were stirred in DCM for 30 
minutes, followed by the addition of acetophenone (S/C = 100) and TEAF (0.9 mL).  The 
reaction was monitored similar to that when using the IPA hydrogen source.   
 (S)-2-(benzyloxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid 65129 
To a suspension of 59 (5.00 g, 19.45 mmoles) in dioxane (80 mL) and water (40 mL) was added 
NaHCO3 (77.80 mmoles) at 0 °C following Schotten-Baumann conditions.  After addition of the 
base, Cbz-Cl (3.64 g/ 3.01 mL, 21.40 mmoles) was added and the reaction was allowed to stir at 
0 °C for 1.5 hours and then at room temperature for a further 1.5 hours.  The product was 
extracted twice with ethyl acetate (~ 25 ml), the organic layer dried with anhydrous magnesium 
sulphate and concentrated to dryness affording 65 (5.56 g, 92 % yield) that was carried forward 
without any purification.  1H and 13C NMR were used to confirm 65.    
General Procedure for the Preparation of 76a-g 
Method adapted from literature.141  (S)-2-(benzyloxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-
carboxylic acid 65 (1.50 g, 4.80 mmoles) was dissolved in DMF (15.00 mL) followed by 
addition of EDC.HCl (1.10 g, 5.80 mmoles), HOBt (0.81 g, 5.30 mmoles), a catalytic amount of 
DMAP and the appropriate amines (5.30 mmols).  The reaction was then stirred at room 
temperature until no more starting material could be detected by TLC analysis (solvent 50:50 
EtOAc:Hex) approximately one hour.  The reaction was poured into 30 volumes of chilled 
water.  The mixture was then extracted twice with ethyl acetate (25.00 ml).  The extracts were 
combined, washed with 10 % HCl (aq) to remove latent EDC urea, dried over anhydrous 
magnesium sulphate and then concentrated to dryness affording the crude product which was 
purified by column chromatography.  
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General Procedure for the Preparation of 77a-g 
The method was adapted from the literature.129  The precursors 77a-g (0.80 g)  in 50:50 
MeOH:THF (12:12 mL) with half an equivalent by mass (0.40 g) of 10 % palladium on carbon 
Pd/C was stirred under hydrogen (approximately 1 atm) for two hours.  The reaction was limited 
to this period as additional side products were observed.  The crude product was obtained by 
filtering off the Pd/C through a plug of celite, the filtrate was then concentrated to dryness and 
the residue purified by column chromatography.   
General Procedure for the Preparation of 78a-g 
The amine amides 77a-g (0.25 g) were reduced with four equivalents of LiAlH4 (~ 0.11 g) in 
refluxing dry THF (~ 9 mL) under a nitrogen atmosphere for 3-4 days or alternatively the 
reductions could be carried out at 85 °C in a microwave reactor for 4-5 hours.  The reactions 
were quenched by slow addition of saturated sodium sulphate solution and the white aluminium 
sulphate precipitate was then filtered.  The filtrate was washed with water (~ 5 mL), dried over 
anhydrous magnesium sulphate and concentrated to dryness affording the crude product which 
was purified by column chromatography.  
(1R,3S)-6,7-dihydroxy-1-phenyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid 6156, 131 
This compound was prepared as reported previously.  1H NMR (400 MHz, D2O) δ = 7.37 – 7.24 
(m, 3H), 7.21-7.13 (m, 2H), 6.67 (s, 1H), 6.29 (s, 1H), 5.30 (s, 1H), 3.58 (dd, J = 10.1, 5.1 Hz, 
1H), 3.04 (dd, J = 16.7, 5.1 Hz, 1H), 2.81 (dd, J = 16.6, 10.2 Hz, 1H).  13C NMR (101 MHz, 
D2O) δ = 178.4, 145.6, 144.5, 141.6, 129.2, 128.6, 128.2, 125.2, 124.8, 115.2, 114.5, 58.1, 52.0 
and 29.9.  
(1R,3S)-2-Benzyl-3-methyl-6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinoline-2,3(1H)-
dicarboxylate 6361 
This compound was prepared as it has been reported in the literature.  [α]20D = + 9.54 (c = 0.26 
g/100mL, CHCl3);  IR νmax: 2942 cm-1, 1744 cm-1, 1714 cm-1, 1204 cm-1, 735 cm-1, 698 cm-1.  
HRMS calculated for C27H28NO6 (M + H)+ = 462.1896 m/z, found 462.1916 m/z.  1H NMR (400 
MHz, d6-DMSO, 100 °C):  = 7.367.15 (m, 9H), 7.09 (s, 1H), 6.76 (s, 1H), 5.165.05 (m, 
3H), 3.78 (s, 3H), 3.73 (s, 3H), 3.48 (s, 3H), 3.21 (dd, J = 15.7, 6.0 Hz, 1H), 3.133.04 (m, 2H). 
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(1R,3S)-Methyl 6,7-dimethoxy-1-phenyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylate 6461 
This compound was prepared as it has been reported in literature.  Colourless oil; [α]20D = + 
15.38 (c = 0.26/100 mL, CHCl3).  IR νmax: 2928 cm-1, 2600 cm-1, 1746 cm-1, 1516 cm-1, 1250 
cm-1, 1123 cm-1 and 727 cm-1.  HRMS calculated for C19H22NO4 (M + H)+ = 328.1548 m/z, 
found 328.1547 m/z.  1H NMR (400 MHz, CDCl3)  = 7.357.24 (m, 3H), 7.237.16 (m, 2H), 
6.65 (s, 1H), 6.34 (s, 1H), 5.25 (s, 1H), 3.88 (s, 3H), 3.80 (q, J = 8.6, 5.1 Hz, 1H), 3.71 (s, 3H), 
3.68 (s, 3H), 3.15 (dd, J = 5.1 Hz, 1H) 3.01 (dd, J = 8.7 Hz, 1H)..  
(1R,3S)-6,7-dimethoxy-1-phenyl-1,2,3,4-tetrahydroisoquinolin-3-yl-methanol 14 
This compound was prepared as it has been reported in literature.61  IR: 3264 cm-1, 2832 cm-1, 
1515 cm-1, 1222 cm-1, 1066 cm-1, 981 cm-1, 726 cm-1, 694 cm-1.  [α]20D = + 3.7 (c = 0.27/100 
mL, CH2Cl2).  HRMS calculated for C28H22NO3 (M + H)+ = 300.1600 m/z, found 300.1622 m/z.  
Pale yellow solid; mp 115  117 °C.  1H NMR (400 MHz, CDCl3):  = 7.327.21 (m, 3H), 
7.187.13 (m, 2H), 6.64 (s, 1H), 6.42 (s, 1H), 5.19 (s, 1H), 3.88 (s, 3H), 3.72 (s, 3H), 3.663.60 
(dd, J = 10.76, 2.96 Hz, 1H), 3.493.41 (dd, J = 10.64, 7.81 Hz, 1H), 3.123.02 (m, 1H), 2.70 
(dd, J = 4.56 Hz, 1H), 2.57 (dd, J = 10.28 Hz, 1H); 13C NMR (100 MHz, CDCl3):  147.9, 
147.2, 144.6, 128.7, 128.2, 127.1, 126.7, 111.5, 110.9, 65.7, 58.9, 55.9, 55.8, 48.8 and 30.5.  
(S)-2-(benzyloxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide 66 
Compound 68 (0.40 g, 2.27 mmoles) was protected with a Cbz group, under the conditions 
described in the general procedure to afford 66 (0.63 g, 89 %), a colourless oil after column 
chromatography (EtOAc/Hex = 20:80, Rf ~ 0.5). [α]20D = - 2.3 (c = 0.59 g/100 mL, CH2Cl2).  IR 
νmax: 427 cm-1, 593 cm-1, 675 cm-1, 697 cm-1, 740 cm-1, 908 cm-1, 983 cm-1, 1027 cm-1, 1038 cm-
1, 1091 cm-1, 1119 cm-1, 1216 cm-1, 1348 cm-1, 1403 cm-1, 1496 cm-1, 1605 cm-1, 1661 cm-1, 
2158 cm-1, 2586 cm-1, 2882 cm-1 and 3179 cm-1.  HRMS calculated for C18H18N2O3 (M + Na)+ = 
333.1210 m/z, found 333.1211 m/z. (NMR spectra are reported for a mixture of two rotamers).142 
1H NMR (400 MHz, CDCl3) δ = 7.50 – 7.00 (m, 9H), 5.29 – 4.86 (m, 3H), 4.84 – 4.50 (m, 2H), 
3.37 – 3.02 (m, 2H), the amide protons were not observed.  13C NMR (101 MHz, CDCl3) δ = 





This compound was prepared according to the literature.  Yield 82 %  1H NMR (400 MHz, 
CDCl3) δ = 7.33 – 6.96 (m, 4H), 5.66 (s, 1H), 4.11 – 3.94 (m, 1H), 3.59 (dd, J = 10.6, 5.1 Hz, 
1H), 3.22 (dd, J = 16.5, 5.1 Hz, 1H), 2.87 (dd, J = 16.5, 10.6 Hz, 1H).  13C NMR (101 MHz, 
CDCl3) δ = 175.9, 135.6, 134.0, 129.2, 126.6, 126.2, 125.6, 56.5, 47.6 and 30.8. 
(S)-benzyl 3-(aminomethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate 69 
To a solution of 66 (0.50 g, 1.50 mmoles) in dioxane (3 mL) was added NaBH4 (0.17 g, 4.50 
mmoles).  The mixture was then cooled to 0 °C and acetic acid (0.18 g, 4.50 mmoles) was added 
dropwise.  After addition the reaction was set to reflux for 48 hours to yield 69 as yellow oil.130  
Due to stability problems (decomposition) with the crude product 69 (0.07 g, 15 % in ~ 90 % 
pure by TLC) was carried forward without further purification.  [α]20D = - 15.00 (c = 0.16 g/100 
mL, CH2Cl2).  IR νmax: 426 cm-1, 495 cm-1, 548 cm-1, 565 cm-1, 658 cm-1, 705 cm-1, 746 cm-1, 
810 cm-1, 850 cm-1, 880 cm-1, 1071 cm-1, 1093 cm-1, 1154 cm-1, 1314 cm-1, 1450 cm-1, 1494 cm-
1, 1598 cm-1, 1722 cm-1, 2853 cm-1, 2922 cm-1, 3031 cm-1 and 3288 cm-1.  HRMS calculated for 
C18H20N2O2 (M + H)+ = 297.1595 m/z, found 297.1598 m/z. (NMR spectra are reported for a 
mixture of two rotamers).142 1H NMR (400 MHz, CDCl3) δ = 7.46 – 7.24 (m, 5H), 7.23 – 6.98 
(m, 4H), 5.26 – 5.10 (m, 2H), 4.89 (m, 1H), 4.59 – 4.25 (m, 2H), 3.06 (m, 1H), 2.77 (m, 1H), 
2.70 (dd, J = 8.0, 13.2 Hz, 1 H), 2.59 (m, 1H).  13C NMR (101 MHz, CDCl3) δ = 156.1, 136.6, 
132.5, 129.0, 128.5, 128.5, 128.0, 127.9, 126.7, 126.3, 126.0, 67.3, 52.5, 43.3, 43.1 and 30.7. 
(S)-4-methyl-N-((1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)benzenesulfonamide 71 
Compound 69 (0.06 g, 0.20 mmoles) was treated with TsCl (0.042 g, 0.22 mmoles) and 
triethylamine (TEA) (0.05 g, 0.45 mmoles) in CH2Cl2 (1.50 mL) for 12 hours at room 
temperature.  Water was then added, and the organic layer washed with 1 N HCl (~ 10 mL) and 
then saturated sodium carbonate.  The resulting oil was dried and the deprotection of the Cbz 
group was carried out as described in the general procedure.  The crude oil was purified by 
column chromatography (EtOH:Toluene, 20:80 Rf ~ 0.7) to yield 71 (0.04 g, 60 %) as a pale 
yellow oil: [α]20D = - 13.82 (c = 0.17 g/100 mL, CH2Cl2). HRMS calculated for C17H20N2O2S (M 
+ H)+ = 317.1339 m/z, found 317.1318 m/z.  IR νmax: 430 cm-1, 457 cm-1, 594 cm-1, 696 cm-1, 
735 cm-1, 808 cm-1, 912 cm-1, 1020 cm-1, 1095 cm-1, 1117 cm-1, 1217 cm-1, 1249 cm-1, 1320 cm-
1, 1418 cm-1, 1495 cm-1, 1678 cm-1, 2927 cm-1, 3030 cm-1, 3315 cm-1.  1H NMR (400 MHz, 
CDCl3) δ = 7.76 (d, J = 8.1 Hz, 2H), 7.30 (d, J = 8.8 Hz, 2H), 7.14 – 6.96 (m, 4H), 3.94 (d, J = 
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4.7 Hz, 2H), 3.19 (dd, J = 3.9, 12.7 Hz, 1H), 3.00 (m, 1H), 2.84 (dd, J = 9.0, 12.7 Hz, 1H), 2.71 
(dd, J = 4.4, 16.3 Hz, 1 H), 2.49 (dd, J = 10.9, 16.8 Hz, 1 H), 2.41 (s, 3 H), The NH protons 
were not observed.  13C NMR (101 MHz, CDCl3) δ = 143.4, 136.8, 135.1, 133.3, 129.8, 129.2, 
127.2, 126.4, 126.1, 125.1, 68.3, 52.7, 47.4, 32.2 and 21.5. 
(S)-(1,2,3,4-tetrahydroisoquinolin-3-yl)methanamine 7256 
This compound was prepared as it has been reported in the literature. Yield 30 %  [α]20D =  – 
35.0 (c = 0.17, in 1 N HCl).  IR νmax: 764 cm-1, 1102 cm-1, 1453 cm-1, 1496 cm-1, 1528 cm-1, 
1582 cm-1 and 2879 cm-1.  MP 224 - 226 °C.  HRMS calculated for C10H15N2 (M + H)+ = 
163.1230 m/z, found 163.1192 m/z.  1H NMR (400 MHz, D2O) δ = 7.09-7.20 (m, 4H), 4.15 (s, 
2H), 3.48 (m, 1H), 3.15 (d, 1H), 2.99 (dd, J = 21.2 Hz, 1H) and 2.75 (dd, J = 10.8, 10.4 Hz, 1H). 
Synthesis of (S)-benzyl 3-(methylcarbamoyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate 
76a 
The resultant product from condensation with methylamine was purified by column 
chromatography (EtOAc/Hex = 50:50, Rf ~ 0.4) to afford the methyl substituted TIQ derivative 
76a (1.06 g, 68 %) light yellow oil. [α]20D = - 6.452 (c = 0.62 g/100 mL, CH2Cl2).  IR νmax: 495 
cm-1, 616 cm-1, 696 cm-1, 742 cm-1, 908 cm-1, 1011 cm-1, 1120 cm-1, 1215 cm-1, 1302 cm-1, 1323 
cm-1, 1406 cm-1, 1536 cm-1, 1655 cm-1, 1695 cm-1, 2939 cm-1, 3031 cm-1, 3065 cm-1 and 3314 
cm-1.  HRMS calculated for C19H20N2O3 (M + H)+ = 325.1547 m/z, found 325.1546 m/z.  NMR 
spectra are reported for a mixture of two rotamers.142  1H NMR (400 MHz, d6-DMSO) δ = 7.85 
(m, 1 H), 7.58 – 7.08 (m, 9 H), 5.36 – 4.98 (m, 2 H), 4.86 – 4.28 (m, 2 H), 3.22 – 2.89 (m, 2 H), 
2.60 – 2.52 (m, 1H), 2.47 (d, 4.66 Hz, 3 H).  13C NMR (101 MHz, d6-DMSO) δ = 170.8, 136.7 - 
125.9, 66.4, 54.1, 44.4, 31.3 and 25.6. 
Synthesis of (S)-N-methyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide 77a 
Removal of Cbz and purification by column chromatography (DCM/MeOH/10 % NH3 in CHCl3 
= 87:3:10, Rf ~ 0.4) afforded methyl amide TIQ 77a (0.36 g, 77 %) as a white solid. [α]20D = - 
222.5 (c = 0.20 g/100 mL, CH2Cl2).  IR νmax: 399 cm-1, 435 cm-1, 515 cm-1, 609 cm-1, 674 cm-1, 
738 cm-1, 797 cm-1, 963 cm-1, 1129 cm-1, 1225 cm-1, 1413 cm-1, 1562 cm-1, 1643 cm-1, 2835 cm-
1, 2877 cm-1, 2940 cm-1 and 3302 cm-1.  Melting point 84 – 86 °C.  HRMS calculated for 
C11H14N2O (M + H)+ = 191.1179 m/z, found 191.1183 m/z.  1H NMR (400 MHz, CDCl3) δ = 
7.24 (br s, 1H), 7.19 – 7.11 (m, 3H), 7.03 (m, 1H), 3.99 (d, J = 3.6 Hz, 2H), 3.52 (dd, J = 10.8 
and 5.1 Hz, 1H), 3.24 (dd, J = 16.5 and 5.1 Hz, 1H), 2.85 (d, J = 5.0 Hz, 3H), 2.80 (dd, J = 16.5 
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and 10.8 Hz, 1H), the NH proton of the amine was not observed.  13C NMR (101 MHz, CDCl3) 
δ = 173.7, 135.9, 134.4, 129.2, 126.6, 126.2, 125.5, 56.6, 47.6, 31.0 and 25.8.  
Synthesis of (S)-N-methyl-1-(1,2,3,4-tetrahydroisoquinolin-3-yl)methanamine 78a 
After reduction 78a was purified by column chromatography (DCM/MeOH/10 % NH3 in CHCl3 
= 87:3:10, Rf ~ 0.4).  However this purification was not effective, therefore further refinement 
was achieved by precipitating the compound out as the dihydrochloride salt using a solution of 
HCl gas bubbled in ether, which generated a precipitate when added to the compound in DCM.  
The precipitated salt was filtered and washed with a 90:10 mixture of ether:DCM affording 78a 
(0.03 g, 15 %) a light brown solid. [α]20D = - 1.3 (c = 0.1 g/100 mL, MeOH).  IR νmax: 428 cm-1, 
448 cm-1, 763 cm-1, 1025 cm-1, 1451 cm-1, 2598 cm-1, 2717 cm-1, 2941 cm-1 and 3395 cm-1.  
HRMS calculated for C11H16N2 (M + H)+ = 177.1386 m/z, found 177.1389 m/z.  1H NMR (400 
MHz, MeOD) δ = 7.13 – 7.26 (m, 4 H), 4.42 (s, 2 H), 3.94 (m, 1 H), 3.46 (dd, J = 13.6 & 6.5 
Hz, 1 H), 3.37 (dd, J = 13.6 and 5.6 Hz, 1 H), 3.24 (m, 1 H), 3.03 (dd, J = 17.1 & 11.0 Hz, 1 H) 
and 2.76 (s, 3 H), the two NH protons were not observed in the spectra. 13C NMR (101 MHz, 
MeOD) δ = 130.9, 130.2, 129.5, 128.7, 128.4, 127.7, 51.8, 51.2, 46.0, 34.4 and 30.4. 
Synthesis of (S)-benzyl 3-(isopropylcarbamoyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate 
76b 
The resultant product from the reaction with isopropylamine and 65 was purified by column 
chromatography (EtOAc/Hex = 50:50, Rf ~ 0.45) to afford 76b (1.43 g, 85 %) as a beige 
powder. [α]20D = - 3.5 (c = 0.58 g/100 mL, THF).  IR νmax: 695 cm-1, 733 cm-1, 749 cm-1, 1124 
cm-1, 1212 cm-1, 1311 cm-1, 1408 cm-1, 1546 cm-1, 1644 cm-1, 1701 cm-1, 2970 cm-1 and 3299 
cm-1.  MP = 95 – 97 °C.  HRMS calculated for C21H24N2O3 (M + H)+ = 353.1860 m/z, found 
353.1860 m/z.  NMR spectra are reported for a mixture of two rotamers.142  1H NMR (400 MHz, 
d6-DMSO) δ = 7.69 (m, 1H), 7.53 – 7.01 (m, 9H), 5.33 – 4.84 (m, 2H), 4.78 – 4.35 (m, 3 H), 
3.72 (m, 1 H), 3.21 – 2.81 (m, 2 H), 0.99 – 0.82 (m, 6 H).  13C NMR (101 MHz, d6-DMSO) δ = 
169.6, 155.2 - 125.8, 67.0, 55.2, 44.6, 40.5, 31.8 and 22.1. 
Synthesis of (S)-N-isopropyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide 77b 
Removal of Cbz and purification by column chromatography (DCM/MeOH/10 % NH3 in CHCl3 
= 87:3:10, Rf ~ 0.5) afforded the isopropyl amide TIQ 77b (0.46 g, 92 %) as a white solid. [α]20D 
= - 105.7 (c = 0.35 g/100 mL, CH2Cl2).  IR νmax: 402 cm-1, 406 cm-1, 619 cm-1, 683 cm-1, 734 
cm-1, 1159 cm-1, 1219 cm-1, 1365 cm-1, 1451 cm-1, 1493 cm-1, 1544 cm-1, 1640 cm-1, 2929 cm-1, 
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2973 cm-1 and 3292 cm-1.  Melting point 87 – 89 °C.  HRMS calculated for C13H18N2O (M + H)+ 
= 219.1492 m/z, found 219.1501 m/z.  1H NMR (400 MHz, CDCl3) δ = 7.12 – 7.19 (m, 3H), 
7.08 – 6.93 (m, 2H), 4.10 (m, 1H), 4.00 (d, J = 4.1 Hz, 2H), 3.50 (dd, J = 10.7 and 5.0 Hz, 1H), 
3.24 (dd, J = 16.5 and 5.0 Hz, 1H), 2.80 (dd, J = 16.5 and 10.7 Hz, 1H), 1.19 (d, J = 6.6 Hz, 
3H), 1.16 (d, J = 6.5 Hz, 3H), the NH proton of the amine was not observed.  13C NMR (101 
MHz, CDCl3) δ = 172.1, 135.8, 134.4, 129.2, 126.6, 126.1, 125.5, 56.6, 47.7, 40.8, 31.1, 22.8, 
22.7. 
Synthesis of (S)-N-((1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)propan-2-amine 78b 
After reduction of 77e, the crude compound was purified by column chromatography 
(EtOAc:MeOH = 95:5, Rf ~ 0.5), yielding an off white-solid 78b (0.11 g, 46 %).  [α]20D = - 8.3 
(c = 0.12 g/100 mL, CH2Cl2).  IR νmax: 695 cm-1, 729 cm-1, 1118 cm-1, 1216 cm-1, 1302 cm-1, 
1322 cm-1, 1400 cm-1, 1650 cm-1, 1680 cm-1, 3029 cm-1 and 3331 cm-1.  MP = 39 – 41 °C.  
HRMS calculated for C13H20N2 (M + H)+ = 205.1699 m/z, found 205.1708 m/z.   1H NMR (400 
MHz, CDCl3) δ = 7.15 – 6.99 (m, 4H), 4.05 (s, 2H), 3.02 – 2.90 (m, 1H), 2.71 – 2.87 (m, 3H), 
2.60 – 2.52 (m, 2 H), 1.09 (overlapping-d, J = 6.5 Hz, 6H), the two NH protons were not 
observed.  13C NMR (101 MHz, CDCl3) δ = 136.0, 134.5, 129.2, 126.0, 126.0, 125.7, 53.9, 52.9, 
49.0, 48.3, 33.5, 23.1 and 23.0. 
Synthesis of (S)-benzyl 3-(phenylcarbamoyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate 
76c 
The resultant product from condensation with aniline was purified by column chromatography 
(EtOAc/Hex = 40:60, Rf ~ 0.5) to afford the aniline substituted TIQ derivative 76c (1.54 g, 83 
%) as a light-yellow oil. [α]20D = - 38.1 (c = 0.42 g/100 mL, CH2Cl2).  IR νmax: 487 cm-1, 693 
cm-1, 736 cm-1, 749 cm-1, 960 cm-1, 1099 cm-1, 1127 cm-1, 1184 cm-1, 1413 cm-1, 1546 cm-1, 
1665 cm-1, 1701 cm-1, 3027 cm-1 and 3301 cm-1.  MP = 137 – 139 °C.  HRMS calculated for 
C24H22N2O3 (M + H)+ = 387.1703 m/z, found 387.1689 m/z.  NMR spectra are reported for a 
mixture of two rotamers.142 1H NMR (400 MHz, d6-DMSO) δ = 10.04 (d, J = 5.1 Hz, 1H), 7.62 
– 6.85 (m, 14H), 5.22 -5.02 (m, 3H), 4.90 – 4.51 (m, 2H), 3.33 – 3.02 (m, 2H).  13C NMR (101 
MHz, d6-DMSO) δ = 169.9, 155.3 - 119.2, 66.5, 54.9, 44.8 and 31.8. 
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Synthesis of (S)-N-phenyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide 77c 
Removal of Cbz group from the aniline amide TIQ 77c (0.46 g, 88 %) formed as a white solid, 
which required no further purification. [α]20D = - 144.7 (c = 0.38 g/100 mL, CH2Cl2).  IR νmax: 
440 cm-1, 551 cm-1, 695 cm-1, 736 cm-1, 1060 cm-1, 1190 cm-1, 1258 cm-1, 1364 cm-1, 1408 cm-1, 
1496 cm-1, 1597 cm-1, 1697 cm-1, 2891 cm-1, 2927 cm-1, 2968 cm-1, 3045 cm-11and 3299 cm-1.  
MP = 183 – 192 °C.  HRMS calculated for C16H17N2O (M + H)+ = 253.1317 m/z, found 
253.1335 m/z.   1H NMR (400 MHz, CDCl3) δ = 9.39 (s, 1 H), 7.60 (d, J = 7.8 Hz, 2 H), 7.33 (t, 
J = 7.8 Hz, 2H), 7.01 – 7.25 (m, 5H), 4.05 (d,  J = 5.4  Hz, 2H), 3.73 (dd, J = 10.3 and 5.3 Hz, 
1H), 3.37 (dd, J = 16.4 and 5.3 Hz, 1H), 2.95 (dd, J = 16.4 and 10.3 Hz, 1H), the NH proton of 
the amine was not observed.  13C NMR (101 MHz, CDCl3) δ = 171.1, 137.7, 135.8, 134.3, 
129.2, 129.1, 126.9, 126.4, 125.5, 124.1, 119.4, 56.7, 47.3 and 30.5. 
Synthesis of (S)-N-((1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)aniline 78c62 
After reduction of 77c, the crude compound was purified by column chromatography (100 % 
diethyl ether, Rf ~ 0.5), yielding a white solid 78c (0.13 g, 57 %).  [α]20D = - 64.29 (c = 0.14 
g/100 mL, CH2Cl2).  IR νmax: 435 cm-1, 488 cm-1, 513 cm-1, 585 cm-1, 690 cm-1, 743 cm-1, 805 
cm-1, 1258 cm-1, 1346 cm-1, 1494 cm-1, 1600 cm-1, 2792 cm-1, 2929 cm-1, 3218 cm-1 and 3301 
cm-1.  MP = 90 – 92 °C.  HRMS calculated for C16H19N2 (M + H)+ = 239.1543 m/z, found 
239.1543 m/z.  1H NMR (400 MHz, CDCl3) δ = 7.23 – 6.99 (m, 6 H), 6.76 – 6.62 (m, 3H), 4.23 
(br s, NH, 1H),  4.07 (br s, 2H), 3.36 (d, J  = 12.1 Hz, 1H), 3.22 (m, 1H), 3.10 (m, 1H), 2.85 (dd, 
J = 16.3 and 4.1 Hz, 1H), 2.66 (dd, J  = 16.3 and 10.5 Hz, 1H), only a single NH proton was 
observed.  13C NMR (101 MHz, CDCl3) δ = 148.4, 135.7, 134.0, 129.3, 129.3, 126.2, 126.0, 
125.9, 117.5, 113.0, 53.0, 49.2, 48.1 and 33.1. 
Synthesis of (S)-benzyl 3-(benzylcarbamoyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate 
76d 
The crude product 76d was purified by column chromatography (EtOAc/Hex = 50:50, Rf ~ 
0.45), isolated as a white powder (1.44 g, 75 %). [α]20D = - 8.3 (c = 0.12 g/100 mL, CH2Cl2).  IR 
νmax: 695 cm-1, 729 cm-1, 1118 cm-1, 1216 cm-1, 1302 cm-1, 1322 cm-1, 1400 cm-1, 1650 cm-1, 
1680 cm-1, 3029 cm-1 and 3331 cm-1.  MP = 105 – 107 °C.  HRMS calculated for C25H24N2O3 
(M + H)+ = 401.1867 m/z, found 401.1860 m/z. (NMR spectra are reported for a mixture of two 
rotamers).142 1H NMR (400 MHz, d6-DMSO) δ = 8.42 (m, 1H), 7.51 – 7.07 (m, 12H), 6.91-
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6.76 (m, 2H), 5.27 – 5.07 (m, 2H), 4.87 – 4.42 (m, 3H), 4.28-4.05 (m, 2H), 3.26-3.06 (m, 2H);  
13C NMR (101 MHz, d6-DMSO) δ = 170.6, 139.2 - 126.1, 66.4, 54.5, 44.7, 41.8 and 31.8. 
Synthesis of (S)-N-benzyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide 77d 
Removal of Cbz from 76d, after purification by column chromatography (DCM/MeOH/10 % 
NH3 in CHCl3 = 87:3:10, Rf ~ 0.4) gave the benzyl amide TIQ 77d (0.45 g, 85 %) as a white 
solid. [α]20D = - 54.76 (c = 0.42 g/100 mL, CH2Cl2).  IR νmax: 435 cm-1, 467 cm-1, 613 cm-1, 694 
cm-1, 736 cm-1, 797 cm-1, 1029 cm-1, 1222 cm-1, 1453 cm-1, 1546 cm-1, 1643 cm-1, 2925 cm-1, 
3033 cm-1, 3057 cm-1, 3279 cm-1 and 3330 cm-1.  MP = 83 – 85 °C.  HRMS calculated for 
C17H18N2O (M + H)+ = 267.1492 m/z, found 267.1504 m/z.  1H NMR (400 MHz, CDCl3) δ = 
7.56 (s, 1H), 7.42 – 7.12 (m, 9H), 4.48 (d, J = 5.6 Hz, 2H), 4.05 – 3.91 (d, J = 6.5 Hz, 2H), 3.61 
(dd, J = 10.3, 5.2 Hz, 1H), 3.28 (dd, J = 16.4, 5.2 Hz, 1H), 2.88 (dd, J = 16.4, 10.3 Hz, 1H), The 
NH proton was not observed.  13C NMR (101 MHz, CDCl3) δ = 173.0, 138.3, 135.9, 134.4, 
129.2, 128.7, 127.7, 127.4, 126.6, 126.2, 125.5, 56.5, 47.5, 43.1 and 31.0. 
Synthesis of (S)-N-benzyl-1-(1,2,3,4-tetrahydroisoquinolin-3-yl)methanamine 78d 
After reduction of 77d (0.25 g), the crude compound was purified by column chromatography 
(DCM/MeOH/Et2O/10 % NH3 in CHCl3 = 66:4:20:10, Rf ~ 0.4) to afford the N-benzyl amine 
derivative 78d (0.07 g, 31 %) as an off-white/yellow solid. [α]20D = - 70.93 (c = 0.43 g/100 mL, 
CH2Cl2).  IR νmax: 695 cm-1, 729 cm-1, 1118 cm-1, 1216 cm-1, 1302 cm-1, 1322 cm-1, 1400 cm-1, 
1650 cm-1, 1680 cm-1, 3029 cm-1 and 3331 cm-1.  MP = 85 – 87 °C.  HRMS calculated for 
C17H21N2 (M + H)+ = 253.1699 m/z, found 253.1708 m/z.  1H NMR (400 MHz, CDCl3) δ = 7.38 
– 7.30 (m, 4H), 7.28 – 7.23 (m, 1H), 7.16 – 6.99 (m, 4H), 4.04 (s, 2H), 3.84 (d, J = 2.8 Hz, 2H), 
3.05 – 2.96 (m, 1H), 2.86 (dd, J = 11.9 and 3.8 Hz, 1H), 2.73 (dd, J = 16.3 and 4.0 Hz, 1H), 2.64 
(dd, J = 11.9 and 8.9 Hz, 1H), 2.59 – 2.51 (m, 1H), the two NH protons were not observed.  13C 
NMR (101 MHz, CDCl3) δ = 140.3, 135.8, 134.4, 129.2, 128.4, 128.1, 127.0, 126.1, 126.0, 
125.7, 54.4, 54.1, 53.4, 48.2 and 33.3. 
Synthesis of (S)-benzyl 3-(benzhydrylcarbamoyl)-3,4-dihydroisoquinoline-2(1H)-
carboxylate 76e 
The resultant product from the reaction with diphenylmethanime was purified by column 
chromatography (EtOAc/Hex = 50:50, Rf ~ 0.4) to afford the diphenyl-substituted TIQ 
derivative 76e (1.62 g, 71 %) light yellow oil. [α]20D = - 11.43 (c = 0.36 g/100 mL, CH2Cl2).  IR 
νmax: 528 cm-1, 546 cm-1, 604 cm-1, 616 cm-1, 639 cm-1, 695 cm-1, 738 cm-1, 909 cm-1, 1001 cm-1, 
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1028 cm-1, 1094 cm-1, 1120 cm-1, 1215 cm-1, 1303 cm-1, 1346 cm-1, 1403 cm-1, 1453 cm-1, 1494 
cm-1, 1658 cm-1, 1696 cm-1, 2851 cm-1, 2925 cm-1, 3029 cm-1 and 3300 cm-1.  HRMS calculated 
for C31H28N2O3 (M + H)+ = 477.2137 m/z, found 477.2155 m/z. NMR spectra are reported for a 
mixture of two rotamers.142   1H NMR (400 MHz, d6-DMSO) δ = 8.95 – 8.69 (m, 1H), 7.64 – 
6.88 (m, 19H), 6.11 – 5.85 (m, 1H), 5.30 – 4.37 (m, 5H), 3.02 -3.27 (m, 2H).  13C NMR (101 
MHz, d6-DMSO) δ = 170.2, 155.3 - 125.9, 86.6, 66.4, 54.8, 44.8 and 32.1. 
Synthesis of (S)-N-benzhydryl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide 77e 
Removal of Cbz and purification by column chromatography (DCM/MeOH/10 % NH3 in CHCl3 
= 87:3:10, Rf ~ 0.4) gave the diphenylmethamide TIQ 77e (0.46 g, 80 %) as a light brown solid. 
[α]20D = - 105.7 (c = 0.35 g/100 mL, CH2Cl2).  IR νmax: 402 cm-1, 406 cm-1, 619 cm-1, 683 cm-1, 
734 cm-1, 1159 cm-1, 1219 cm-1, 1365 cm-1, 1451 cm-1, 1493 cm-1, 1544 cm-1, 1640 cm-1, 2929 
cm-1, 2973 cm-1 and 3292 cm-1.  HRMS calculated for C23H22N2O (M + H)+ = 343.1795 m/z, 
found 343.1805 m/z.  1H NMR (400 MHz, CDCl3) δ = 7.97 – 8.10 (m, 1H), 7.42 – 6.95 (m, 
14H), 7.09 – 7.02 (m, 1H), 4.08 – 3.95 (m, 2H), 3.58 – 3.40 (m, 1H), 3.31 – 3.19 (m, 1H), 2.99 – 
2.87 (m, 1H), the NH proton of the amine was not observed in the spectra.  13C NMR (101 MHz, 
CDCl3) δ = 172.0, 141.6, 141.5, 129.1 – 125.3, 56.4, 56.2, 47.1 and 30.3 
Synthesis of (S)-1,1-diphenyl-N-((1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)methanamine 
78e 
After the reduction of 77e (0.25 g), the crude compound was purified by column 
chromatography (MeOH/Et2O = 5:95, Rf ~ 0.6) to afford the N-diphenylmethanamine amine 
derivative 78e (0.05 g, 21 %) as a yellow solid. [α]20D = - 55.77 (c = 0.52 g/100 mL, CH2Cl2).  
IR νmax: 430 cm-1, 696 cm-1, 706 cm-1, 743 cm-1, 800 cm-1, 1027 cm-1, 1429 cm-1, 1447 cm-1, 
1490 cm-1, 1580 cm-1, 1595 cm-1, 2780 cm-1, 2911 cm-1, 3289 cm-1, and 3324 cm-1.  MP = 89 – 
91 °C.  HRMS calculated for C23H25N2 (M + H)+ = 329.2012 m/z, found 329.2004 m/z.  1H 
NMR (600 MHz, CDCl3) δ = 7.43 – 6.98 (m, 14 H), 4.87 (s, 1 H), 4.06 (s, 2 H), 3.00 (m, 1 H), 
2.83 (dd, J = 11.8 and 3.8 Hz, 1H), 2.73 (dd, J = 16.2 and 3.9 Hz, 1H), 2.64 (dd, J = 11.8 and 8.7 
Hz, 1H), 2.56 (dd, J = 16.2 and 10.8 Hz, 1H), the two NH protons were not observed. 13C NMR 
(151 MHz, CDCl3) δ = 144.2, 143.9, 135.9, 134.5, 129.2, 128.5, 127.3, 127.3, 127.0, 126.1, 
126.0, 125.7, 67.7, 53.7, 53.6, 48.3 and 33.4.  
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Synthesis of (S)-benzyl 3-((R)-1-phenylethylcarbamoyl)-3,4-dihydroisoquinoline-2(1H)-
carboxylate 76f 
The resultant product from the reaction with (R)-1-phenylethanamine was purified by column 
chromatography (EtOAc/Hex = 50:50, Rf ~ 0.4) to afford the (R)-1-phenylethanamine-
substituted TIQ derivative 76f (1.55 g, 78 %) as a light-yellow oil. [α]20D = + 10.7 (c = 1.03 
g/100 mL, CH2Cl2).  IR νmax: 491 cm-1, 599 cm-1, 696 cm-1, 740 cm-1, 905 cm-1, 1001 cm-1, 1093 
cm-1, 1119 cm-1, 1214 cm-1, 1302 cm-1, 1322 cm-1, 1347 cm-1, 1400 cm-1, 1448 cm-1, 1522 cm-1, 
1638 cm-1, 1697 cm-1, 2932 cm-1, 3029 cm-1, 3062 cm-1 and 3315 cm-1.  HRMS calculated for 
C26H26N2O3 (M + H)+ = 415.2016 m/z, found 415.1998 m/z.  NMR spectra are reported for a 
mixture of two rotamers.142  1H NMR = (400 MHz, d6-DMSO) δ = 8.24 (m, 1H), 7.53 – 6.91 (m, 
14H), 5.32 – 4.96 (m, 2H), 4.93 – 4.41 (m, 4H), 3.20 – 3.02 (m, 2H), 1.25 (d, J = 7.1 Hz, 3H).  
13C NMR (101 MHz, d6-DMSO) δ = 170.1, 144.1 - 125.6, 66.4, 54.4, 47.5, 44.7, 32.0 and 22.0. 
Synthesis of (S)-N-((R)-1-phenylethyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide 77f 
Removal of Cbz and purification by column chromatography (Et2O:Acetone = 80:20, Rf ~ 0.5) 
gave the (R)-1-phenylethanamide TIQ 77f (0.39 g, 72 %) as a white solid. [α]20D = - 33.8 (c = 
0.34 g/100 mL, CH2Cl2).  IR νmax: 430 cm-1, 583 cm-1, 617 cm-1, 695 cm-1, 733 cm-1, 748 cm-1, 
790 cm-1, 803 cm-1, 1180 cm-1, 1221 cm-1, 1446 cm-1, 1492 cm-1, 1544 cm-1, 1643 cm-1, 2838 
cm-1, 2926 cm-1 and 3284 cm-1.  MP = 119 – 121 °C.  HRMS calculated for C18H21N2O (M + 
H)+ = 281.1648 m/z, found 281.1645 m/z.   1H NMR (400 MHz, CDCl3) δ = 7.52 (d, J = 8.0 Hz, 
1H), 7.34 – 7.27 (m, 2H), 7.26 – 7.20 (m, 3H), 7.20 – 7.12 (m, 3H), 7.04 (m, 1H), 5.14 (m, 1H), 
3.99 (d, J = 11.8 Hz, 2H), 3.59 (dd, J = 10.2 and 5.2 Hz, 1H), 3.23 (dd, J = 16.4 and 5.2 Hz, 
1H), 2.82 (dd, J = 16.4 and 10.2 Hz, 1H), 1.51 (d, J = 6.9 Hz, 3H), the NH proton of the amine 
was not observed.  13C NMR (101 MHz, CDCl3) δ = 172.2, 143.3, 135.9, 134.4, 129.2, 128.6, 
127.2, 126.6, 126.2, 126.0, 125.5, 56.4, 48.1, 47.6, 31.0 and 22.0. 
Synthesis of (R)-1-phenyl-N-(((S)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)ethanamine 
78f 
After reduction of 77f (0.25 g), the crude compound was purified by column chromatography 
(DCM/MeOH/10 % NH3 in CHCl3 = 87:4:10, Rf ~ 0.5) to yield 78f (0.07 g, 30 %), a light-
yellow oil. [α]20D = - 43.55 (c = 0.93 g/100 mL, CH2Cl2).  IR νmax: 431 cm-1, 543 cm-1, 695 cm-1, 
783 cm-1, 1118 cm-1, 1451 cm-1, 1492 cm-1, 2789 cm-1, 2918 cm-1, 2960 cm-1, 3026 cm-1 and 
3240 cm-1.  HRMS calculated for C18H23N2 (M + H)+ = 267.1856 m/z, found 267.1846 m/z.  1H 
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NMR (400 MHz, CDCl3) δ = 7.33 – 7.29 (m, 4H), 7.21 (m, 1H), 7.10 – 7.05 (m, 2H), 7.03 – 
6.96 (m, 2H), 3.96 (d, J = 16.8 Hz, 2H), 3.74 (m, 1H), 2.82 (m, 1H), 2.66 – 2.61 (m, 2H), 2.51 – 
2.42 (m, 2H), 1.37 (d, J = 6.7 Hz, 3H), the two NH protons were not observed.  13C NMR (101 
MHz, CDCl3) δ = 145.6, 135.9, 134.5, 129.2, 128.4, 126.9, 126.5, 126.0, 126.0, 125.6, 58.2, 
53.7, 52.8, 48.3, 33.3 and 24.6. 
Synthesis of (S)-benzyl 3-((S)-1-phenylethylcarbamoyl)-3,4-dihydroisoquinoline-2(1H)-
carboxylate 76g 
The resultant product from reaction with (S)-1-phenylethanamine was purified by column 
chromatography (EtOAc/Hex = 50:50, Rf ~ 0.4) to afford the (S)-1-phenylethanamine 
substituted TIQ derivative 76g (1.77 g, 89 %) as a light-yellow oil. [α]20D = - 21.4 (c = 0.70 
g/100 mL, CH2Cl2).  IR νmax: 696 cm-1, 738 cm-1, 1059 cm-1, 1119 cm-1, 1213 cm-1, 1303 cm-1, 
1329 cm-1, 1407 cm-1, 1449 cm-1, 1495 cm-1, 1534 cm-1, 1656 cm-1, 1697 cm-1, 2972 cm-1, 3029 
cm-1, 3062 cm-1 and 3299 cm-1.  HRMS calculated for C26H27N2O3 (M + H)+ = 415.2016 m/z, 
found 415.2009 m/z.  NMR spectra are reported for a mixture of two rotamers.142  1H NMR (400 
MHz,d6- DMSO) δ = 8.29 (m, 1H), 7.49 – 6.91 (m, 14H), 5.22 – 4.99 (m, 2H), 4.86 – 4.41 (m, 
4H), 3.23 – 2.97 (m, 2H), 1.30 – 1.13 (m, 3H).  13C NMR (101 MHz, d6-DMSO) δ = 169.9, 
154.9 - 125.5, 66.3, 54.1, 47.5, 44.7, 31.8, 22.1. 
Synthesis of (S)-N-((S)-1-phenylethyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide 77g 
Removal of Cbz and purification by column chromatography (Et2O:Acetone = 80:20, Rf ~ 0.5) 
afforded the (S)-1-phenylethanamide TIQ 77g (0.41 g, 76 %) as a beige solid. [α]20D = - 100.7 (c 
= 0.36 g/100 mL, CH2Cl2).  IR νmax: 428 cm-1, 449 cm-1, 525 cm-1, 551 cm-1, 609 cm-1, 643 cm-1, 
697 cm-1, 734 cm-1, 750 cm-1, 780 cm-1, 1077 cm-1, 1137 cm-1, 1225 cm-1, 1248 cm-1, 1493 cm-1, 
1533 cm-1, 1646 cm-1, 2926 cm-1, 2966 cm-1 and 3333 cm-1.  MP = 119 – 121 °C.  HRMS 
calculated for C18H21N2O (M + H)+ = 281.1648 m/z, found 281.1644 m/z.  1H NMR (400 MHz, 
CDCl3) δ = 7.48 (m, 1H), 7.38 – 7.11 (m, 8H), 7.04 (m, 1H), 5.13 (m, 1H), 3.99 (s, 2H), 3.53 
(dd, J = 10.5, 5.1 Hz, 1H), 3.23 (dd, J = 16.5, 5.1 Hz, 1H), 2.85 (dd, J = 16.5 and 10.5 Hz, 1H), 
1.48 (d, J = 6.9 Hz, 3H), NH proton of the amine was not observed.  13C NMR (101 MHz, 
CDCl3) δ = 172.1, 143.3, 135.7, 134.3, 129.2, 128.7, 128.5, 127.3, 126.6, 126.2, 125.5, 56.5, 
48.3, 47.5, 31.0 and 22.0. 
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Synthesis of (S)-1-phenyl-N-(((S)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)ethanamine 
78g 
After reduction of 77g (0.25 g), the crude compound was purified by column chromatography 
(DCM/MeOH/10 % NH3 in CHCl3 = 87:4:10, Rf ~ 0.5) to yield 78g (0.08 g, 35 %), as a light-
yellow oil, which was then also stored as the dihydrochloride salt. [α]20D = - 43.6 (c = 0.93 g/100 
mL, CH2Cl2).  IR νmax: 431 cm-1, 543 cm-1, 695 cm-1, 783 cm-1, 1118 cm-1, 1451 cm-1, 1492 cm-1, 
2789 cm-1, 2918 cm-1, 2960 cm-1, 3026 cm-1 and 3240 cm-1.  HRMS calculated for C18H23N2 (M 
+ H)+ = 267.1856 m/z, found 267.1846 m/z.  1H NMR (400 MHz, MeOD) δ = 7.58 – 7.10 (m, 9 
H), 4.52 – 4.31 (m, 3 H), 3.87 (m, 1 H), 3.49 (m, 1 H), 3.19 – 3.01 (m, 3 H), 1.71 (d, J = 6.7, 3 
H). 13C NMR (101 MHz, MeOD) δ = 137.1, 131.0, 130.6, 130.1, 129.4, 129.0, 128.7, 128.6, 
128.3, 127.7, 61.3, 52.5, 48.5, 46.0, 30.6 and 19.5. 
Synthesis of (1R,3S)-benzyl 3-(hydroxymethyl)-6,7-dimethoxy-1-phenyl-3,4-
dihydroisoquinoline-2(1H)-carboxylate 79 
Compound 9143 (1.00 g, 3.34 mmoles) was protected with a Cbz group under the conditions 
described in the general procedure to afford 79 (1.31 g, 91 %) as a light-yellow oil after column 
chromatography (EtOAc/Hex = 60:40, Rf ~ 0.5). [α]20D = + 40.38 (c = 0.26 g/100 mL, CH2Cl2).  
IR νmax: 697 cm-1, 1088 cm-1, 1220 cm-1, 1285 cm-1, 1337 cm-1, 1404 cm-1, 1516 cm-1, 1638 cm-
1, 1688 cm-1, 2247 cm-1, 3301 cm-1 and 3553 cm-1.  HRMS calculated for C26H28NO5 (M + H)+ = 
434.1928 m/z, found 434.1962 m/z.  NMR spectra are reported for a mixture of two rotamers.142 
1H NMR (400 MHz, CDCl3) δ = 7.43 – 6.92 (m, 10H), 6.78 (s, 1H), 6.66 (s, 1H), 6.01 (s, 1H), 
5.38 – 4.87 (m, 2H), 4.47 (m, 1H), 3.86 (s, 3H), 3.83 (s, 3H), 3.63 (m, 1H), 3.34 (m, 1H), 3.02 – 
2.89 (m, 2H).  13C NMR (101 MHz, CDCl3) δ = 148.4 - 125.3, 112.0, 110.7, 67.5, 64.4, 59.8, 
56.1, 55.9, 54.7 and 29.4. 
(1R,3S)-benzyl 3-((1,3-dioxoisoindolin-2-yl)methyl)-6,7-dimethoxy-1-phenyl-3,4-
dihydroisoquinoline-2(1H)-carboxylate 84 
Compound 79 (0.36 g, 0.83 mmoles), phthalimide (0.18 g, 1.25 mmoles) and triphenylphosphine 
(0.63 g, 2.41 mmoles) were first taken up in 11.50 mL of DCM.  The mixture was kept stirring 
whilst cooled to 0 °C, after which diethyl azidodicarboxylate (0.30 mL, 2.49 mmoles) in 3.00 
mL of DCM was added dropwise.  Thereafter the mixture was allowed to reach room 
temperature and stirred for a further three hours.144  The DCM was then removed under vacuum 
and water was added, the aqueous layer was extracted three times with DCM, followed by a 
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typical work up procedure as outlined in the general procedures.  The product 84 was obtained 
as a yellow oil (55 %)after column chromatography (EtOAc/Hex, 40:60 Rf ~ 0.7).  HRMS 
calculated for C34H31N2O6 (M + H)+ = 563.2177 m/z, found 563.2180 m/z.  IR νmax: 430 cm-1, 
457 cm-1, 594 cm-1, 696 cm-1, 735 cm-1, 808 cm-1, 912 cm-1, 1020 cm-1, 1095 cm-1, 1117 cm-1, 
1217 cm-1, 1249 cm-1, 1320 cm-1, 1418 cm-1, 1495 cm-1, 1678 cm-1, 2927 cm-1, 3030 cm-1, 3315 
cm-1.  1H NMR (400 MHz, CDCl3) δ 7.86 – 7.51 (m, 4H), 7.56 – 7.02 (m, 9H), 6.87 (m, 1H), 
6.47 - 6.68 (m, 2H), 5.92 (m, 1H), 5.27 – 4.76 (m, 3H), 4.01 (m, 1H), 3.93 -  3.53 (m, 7H), 3.22 
(m, 1H), 2.81 (m, 1H).  13C NMR (101 MHz, CDCl3) δ 168.3, 156.1, 147.6, 144.6, 136.4, 133.6, 
132.1, 131.8, 128.8, 128.5, 128.3, 128.1, 127.5, 126.5, 125.9, 125.5, 123.7, 122.6, 112.1, 110.3, 
77.3, 77.0, 76.7, 67.5, 67.1, 59.7, 55.8, 55.7, 51.2, 40.7 and 31.1. 
Synthesis of (1R,3S)-benzyl 3-formyl-6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinoline-
2(1H)-carboxylate 87 
Oxidation of 79 (0.80 g, 1.84 mmoles) with PCC (3 equivalents) and MgSO4 (3 equivalents) in 
dry DCM145 gave 87 (0.45 g, 57 %) as a yellow oil after treatment with wet diethyl ether and 
filtration through a small plug of silica to remove excess PCC and other metal species. [α]20D = + 
41.5 (c = 0.41 g/100 mL, CH2Cl2).  IR νmax: 594 cm-1, 697 cm-1, 737 cm-1, 994 cm-1, 1028 cm-1, 
1092 cm-1, 1221 cm-1, 1264 cm-1, 1339 cm-1, 1397 cm-1, 1513 cm-1, 1692 cm-1, 2838 cm-1 and 
2924 cm-1.  HRMS calculated for C26H25NO5 (M + Na)+ = 454.1625 m/z, found 454.1606 m/z.  
NMR spectra are reported for a mixture of two rotamers.142  1H NMR (400 MHz, CDCl3) δ = 
9.38 (m, 1H), 7.65 – 7.02 (m, 10H), 6.96 – 5.90 (m, 3H), 5.38 – 4.84 (m, 2H), 4.59 (m, 1H), 
3.95 – 3.75 (m, 6H), 3.24 – 2.80 (m, 2H).  13C NMR (101 MHz, CDCl3) δ = 148.5 - 126.0, 
110.7, 67.5, 60.6, 56.0, 55.9 and 29.7. 
Synthesis of (1R,3S)-benzyl 3-((benzylamino)methyl)-6,7-dimethoxy-1-phenyl-3,4-
dihydroisoquinoline-2(1H)-carboxylate 86 
To a 50 % mixture of dry THF in MeOH (6.00 mL) was added compound 11 (0.30 g, 0.69 
mmoles), followed by benzylamine (0.23 g, 2.00 mmoles) and the mixture was allowed to stir at 
room temperature for 3 hours.  The reaction mixture was then cooled to 0 °C with an ice bath, 
followed by slow addition of NaCNBH4 (~ 0.30 g) and stirred for 30 minutes at 0 °C, and a 
further 30 minutes at RT.  Water was added to the reaction and the resultant mixture was 
extracted three times with DCM.  The crude product was purified by column chromatography 
(EtOAc/Hex = 70:30, Rf ~ 0.7) to afford 12 (0.21 g, 60 %) yellow oil. [α]20D = + 27.3 (c = 0.44 
g/100 mL, CH2Cl2).  IR νmax: 593 cm-1, 697 cm-1, 736 cm-1, 999 cm-1, 1028 cm-1, 1092 cm-1, 
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1219 cm-1, 1338 cm-1, 1397 cm-1, 1452 cm-1, 1514 cm-1, 1689 cm-1, 2931 cm-1 and 3028 cm-1.  
HRMS calculated for C33H34N2O4 (M + H)+ = 523.2591 m/z, found 523.2579 m/z.  NMR spectra 
are reported for a mixture of two rotamers.142  1H NMR (400 MHz, CDCl3) δ = 7.41 – 7.10 (m, 
15H), 6.78 (s, 1H), 6.59 (s, 1H), 5.99 (s, 1H), 5.26 – 4.91 (m, 2H), 4.46 (m, 1H), 3.97 – 3.56 (m, 
9H), 3.08 – 2.68 (m, 3H), NH proton of the amine was not observed.  13C NMR (101 MHz, 




Compound 12 (0.1 g, 0.19 mmoles) was treated with palladium on carbon as mentioned in the 
general procedure, to remove the Cbz group.  The reaction was monitored carefully to avoid 
removal of the benzyl group.  Purification by column chromatography (DCM/MeOH/10 % NH3 
in CHCl3 = 87:3:10, Rf ~ 0.5) yielded 88 (0.038 g, 52 %) as a colourless oil. [α]20D = - 26.8 (c = 
0.41 g/100 mL, CH2Cl2).  IR νmax: 573 cm-1, 699 cm-1, 753 cm-1, 819 cm-1, 1057 cm-1, 1127 cm-1, 
1224 cm-1, 1293 cm-1, 1449 cm-1, 1519 cm-1, 1609 cm-1, 2832 cm-1, 2920 cm-1, 2994 cm-1 and 
3060 cm-1.  HRMS calculated for C25H29N2O2 (M + H)+ = 389.2224 m/z, found 389.2224 m/z.   
1H NMR (400 MHz, CDCl3) δ = 7.38 – 7.13 (m, 10H), 6.63 (s, 1H), 6.41 (s, 1H), 5.10 (s, 1H), 
3.86 (s, 3H), 3.70 (s, 3H), 3.55 (s, 2H), 3.02 (m, 1H), 2.74 – 2.67 (m, 2H), 2.59 – 2.47 (m, 2H), 
the two NH protons were not observed. 13C NMR (101 MHz, CDCl3) δ = 147.8, 147.1, 145.3, 
140.3, 128.5, 128.3, 128.3, 128.3, 128.2, 128.1, 127.0, 126.9, 111.4, 111.1, 59.3, 55.9, 55.8, 
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 NMR spectra 
 IR spectra 




1H NMR Spectrum of Compound 59 in CDCl3 






































































































13C NMR Spectrum of Compound 59 in CDCl3 






















































































































1H NMR Spectrum of Compound 65 in CDCl3 













































































































13C NMR Spectrum of Compound 65 in CDCl3 
 























































































































1H NMR Spectrum of Compound 66 in CDCl3 





































































































13C NMR Spectrum of Compound 66 in CDCl3 
 





































































































13C NMR Spectrum of Compound 67 in CDCl3 
 




















































1H NMR Spectrum of Compound 14 in CDCl3 








































































































































































13C NMR Spectrum of Compound 14 in CDCl3 
 









































































































































































































IR Spectrum of Compound 71 



































































IR Spectrum of Compound 76a 





































































IR Spectrum of Compound 77a 





























































































IR Spectrum of Compound 78a 



























































































































































































































































IR Spectrum of Compound 78b 















































































































IR Spectrum of Compound 76c 



































































































IR Spectrum of Compound 77c 
































































































IR Spectrum of Compound 78c 




























































































































IR Spectrum of Compound 76d 















































































IR Spectrum of Compound 77d 

















































































IR Spectrum of Compound 78d 
















































































































IR Spectrum of Compound 76e 







































































1H NMR Spectrum of Compound 77e in CDCl3 
































































































































13C NMR Spectrum of Compound 77e in CDCl3 
 









































































































































IR Spectrum of Compound 78e 

















































































































IR Spectrum of Compound 76f 




























































































IR Spectrum of Compound 77f 




























































































IR Spectrum of Compound 78f 






















































































































IR Spectrum of Compound 76g 



















































































IR Spectrum of Compound 77g 


































































































IR Spectrum of Compound 78g 


























































IR Spectrum of Compound 79 




















































































IR Spectrum of Compound 84 






























































































IR Spectrum of Compound 86 









































































IR Spectrum of Compound 87 









































































IR Spectrum of Compound 88 













































































GC Chromatogram of 1-phenylethanol (racemic) 
